rolandc85 personal page - To The Moon

rolandc85

rolandc85

No personal profile

33Follow

1Followers

0Topic

0Badge

2021-08-08

This is a great stock to own

Sorry, the original content has been removed

2021-08-06

Commented on this

Space Race, Nasdaq, IBM, Nvidia: What to Watch When the Stock Market Opens

2021-08-24

Gd

Baidu's AI voice assistant Xiaodu closes funding at $5.1 billion valuation

2021-08-06

Great

Sorry, the original content has been removed

2021-08-01

Great

Wall Street declines with Amazon; S&P 500 posts gains for month

2021-08-08

Yes heading there

Tesla Stock: Headed to $1,200?

2021-08-04

Ok

Why Clean Energy Fuels Has Plenty of Work To Do

2021-08-05

Good

Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar

2021-08-05

Good

Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar

2021-08-03

Good

Apple Topples Saudi Aramco To Be The Most Profitable Fortune Global 500 Company In 2020

2021-08-24

Like please

Blackstone in talks to buy Baring's Interplex for at least $1 bln -sources

2021-08-13

Great free stock

2021-08-05

Like me please

Sorry, the original content has been removed

2021-08-03

Great

Sorry, the original content has been removed

2021-08-01

Like and shaee

Sorry, the original content has been removed

2021-08-03

Like and comment please

Sorry, the original content has been removed

2021-04-29

Good

Apple reports another blowout quarter with sales up 54%, authorizes $90 billion in share buybacks

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3581829779229670","uuid":"3581829779229670","gmtCreate":1618739777744,"gmtModify":1627867228467,"name":"rolandc85","pinyin":"rolandc85","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":33,"tweetSize":19,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":834264254,"gmtCreate":1629807916978,"gmtModify":1676530137326,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834264254","repostId":"2161000317","repostType":4,"repost":{"id":"2161000317","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629802463,"share":"https://ttm.financial/m/news/2161000317?lang=&edition=fundamental","pubTime":"2021-08-24 18:54","market":"us","language":"en","title":"Blackstone in talks to buy Baring's Interplex for at least $1 bln -sources","url":"https://stock-news.laohu8.com/highlight/detail?id=2161000317","media":"Reuters","summary":"HONG KONG, Aug 24 (Reuters) - Blackstone is in talks to acquire Interplex Holdings, a Singapore-base","content":"<p>HONG KONG, Aug 24 (Reuters) - Blackstone is in talks to acquire Interplex Holdings, a Singapore-based technological services provider owned by Baring Private Equity Asia (BPEA), in a deal worth at least $1 billion, according to two people with knowledge of the matter.</p>\n<p>Final negotiations could still take weeks and there is no certainty in a deal yet, said the sources, who declined to be named as the information is confidential.</p>\n<p>Blackstone has no exclusivity in the deal, they added.</p>\n<p>The U.S-based private equity firm and Hong Kong-based BPEA declined to comment. Interplex did not immediately respond to a request for comment.</p>\n<p>Bloomberg first reported the talks on Tuesday.</p>\n<p>BPEA offered S$450 million ($320 million) to buy out</p>\n<p>Interplex Holdings in December 2015 from CVC Capital Partners and the private equity arm of Standard Chartered .</p>\n<p>Interplex delisted from the Singapore bourse in April 2016 when the transaction was completed.</p>\n<p>The company designs, engineers and delivers advanced applications development and high-precision engineering solutions for customers in over 25 locations across over 13 countries, its website said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Blackstone in talks to buy Baring's Interplex for at least $1 bln -sources</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlackstone in talks to buy Baring's Interplex for at least $1 bln -sources\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 18:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HONG KONG, Aug 24 (Reuters) - Blackstone is in talks to acquire Interplex Holdings, a Singapore-based technological services provider owned by Baring Private Equity Asia (BPEA), in a deal worth at least $1 billion, according to two people with knowledge of the matter.</p>\n<p>Final negotiations could still take weeks and there is no certainty in a deal yet, said the sources, who declined to be named as the information is confidential.</p>\n<p>Blackstone has no exclusivity in the deal, they added.</p>\n<p>The U.S-based private equity firm and Hong Kong-based BPEA declined to comment. Interplex did not immediately respond to a request for comment.</p>\n<p>Bloomberg first reported the talks on Tuesday.</p>\n<p>BPEA offered S$450 million ($320 million) to buy out</p>\n<p>Interplex Holdings in December 2015 from CVC Capital Partners and the private equity arm of Standard Chartered .</p>\n<p>Interplex delisted from the Singapore bourse in April 2016 when the transaction was completed.</p>\n<p>The company designs, engineers and delivers advanced applications development and high-precision engineering solutions for customers in over 25 locations across over 13 countries, its website said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BX":"黑石"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161000317","content_text":"HONG KONG, Aug 24 (Reuters) - Blackstone is in talks to acquire Interplex Holdings, a Singapore-based technological services provider owned by Baring Private Equity Asia (BPEA), in a deal worth at least $1 billion, according to two people with knowledge of the matter.\nFinal negotiations could still take weeks and there is no certainty in a deal yet, said the sources, who declined to be named as the information is confidential.\nBlackstone has no exclusivity in the deal, they added.\nThe U.S-based private equity firm and Hong Kong-based BPEA declined to comment. Interplex did not immediately respond to a request for comment.\nBloomberg first reported the talks on Tuesday.\nBPEA offered S$450 million ($320 million) to buy out\nInterplex Holdings in December 2015 from CVC Capital Partners and the private equity arm of Standard Chartered .\nInterplex delisted from the Singapore bourse in April 2016 when the transaction was completed.\nThe company designs, engineers and delivers advanced applications development and high-precision engineering solutions for customers in over 25 locations across over 13 countries, its website said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834262776,"gmtCreate":1629807853695,"gmtModify":1676530137292,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/834262776","repostId":"2161208319","repostType":4,"repost":{"id":"2161208319","kind":"news","pubTimestamp":1629805385,"share":"https://ttm.financial/m/news/2161208319?lang=&edition=fundamental","pubTime":"2021-08-24 19:43","market":"us","language":"en","title":"Baidu's AI voice assistant Xiaodu closes funding at $5.1 billion valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2161208319","media":"Reuters","summary":"(Reuters) - Chinese tech giant Baidu Inc said on Tuesday its artificial intelligence (AI) voice assi","content":"<p>(Reuters) - Chinese tech giant <a href=\"https://laohu8.com/S/BIDU\">Baidu</a> Inc said on Tuesday its artificial intelligence (AI) voice assistant Xiaodu Technology has closed Series B financing at a $5.1 billion valuation.</p>\n<p>Xiaodu is the developer of DuerOS, a voice assistant system based on AI that supports television, speakers and other smart home appliances. It completed its Series A funding in November 2020 at a post-money valuation of $2.9 billion, said Baidu.</p>\n<p>Earlier in March, Baidu said that its AI chip unit Kunlun also completed a round of fundraising, which according to one source with direct knowledge of the matter valued the business at about $2 billion. </p>\n<p>Baidu said on Tuesday that after the transaction it would remain a majority shareholder.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baidu's AI voice assistant Xiaodu closes funding at $5.1 billion valuation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaidu's AI voice assistant Xiaodu closes funding at $5.1 billion valuation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 19:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/baidus-ai-voice-assistant-xiaodu-110841708.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Chinese tech giant Baidu Inc said on Tuesday its artificial intelligence (AI) voice assistant Xiaodu Technology has closed Series B financing at a $5.1 billion valuation.\nXiaodu is the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/baidus-ai-voice-assistant-xiaodu-110841708.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIDU":"百度"},"source_url":"https://finance.yahoo.com/news/baidus-ai-voice-assistant-xiaodu-110841708.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2161208319","content_text":"(Reuters) - Chinese tech giant Baidu Inc said on Tuesday its artificial intelligence (AI) voice assistant Xiaodu Technology has closed Series B financing at a $5.1 billion valuation.\nXiaodu is the developer of DuerOS, a voice assistant system based on AI that supports television, speakers and other smart home appliances. It completed its Series A funding in November 2020 at a post-money valuation of $2.9 billion, said Baidu.\nEarlier in March, Baidu said that its AI chip unit Kunlun also completed a round of fundraising, which according to one source with direct knowledge of the matter valued the business at about $2 billion. \nBaidu said on Tuesday that after the transaction it would remain a majority shareholder.","news_type":1},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897968152,"gmtCreate":1628868743576,"gmtModify":1676529881998,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Great free stock","listText":"Great free stock","text":"Great free stock","images":[{"img":"https://static.tigerbbs.com/c73301097dba2759a5114cb01c22943c","width":"1200","height":"2686"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897968152","isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":898008164,"gmtCreate":1628438304358,"gmtModify":1703506242495,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"This is a great stock to own","listText":"This is a great stock to own","text":"This is a great stock to own","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/898008164","repostId":"1139912651","repostType":4,"isVote":1,"tweetType":1,"viewCount":423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898001499,"gmtCreate":1628438218211,"gmtModify":1703506241848,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Yes heading there","listText":"Yes heading there","text":"Yes heading there","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/898001499","repostId":"1159872041","repostType":4,"repost":{"id":"1159872041","kind":"news","pubTimestamp":1628385224,"share":"https://ttm.financial/m/news/1159872041?lang=&edition=fundamental","pubTime":"2021-08-08 09:13","market":"us","language":"en","title":"Tesla Stock: Headed to $1,200?","url":"https://stock-news.laohu8.com/highlight/detail?id=1159872041","media":"Motley Fool","summary":"Tesla deliveries more than doubled year over year in Q2.Rising demand for electric vehicles could benefit Tesla.Investors should exercise caution when it comes to analysts' price targets.It's been a wild year for Teslastock. When the year started, shares initially surged more than 20%. But the stock has now given up all of those gains, with a year-to-date return of negative 1%. This means the stock has significantly underperformed the S&P 500's 18% gain this year.In February,Piper Sandler analys","content":"<p><b>Key Points</b></p>\n<ul>\n <li>Tesla deliveries more than doubled year over year in Q2.</li>\n <li>Rising demand for electric vehicles could benefit Tesla.</li>\n <li>Investors should exercise caution when it comes to analysts' price targets.</li>\n</ul>\n<p>It's been a wild year for&nbsp;<b>Tesla</b>(NASDAQ:TSLA)stock. When the year started, shares initially surged more than 20%. But the stock has now given up all of those gains, with a year-to-date return of negative 1%. This means the stock has significantly underperformed the&nbsp;<b>S&amp;P 500</b>'s 18% gain this year.</p>\n<p>But one analyst thinks the stock could take off.</p>\n<p><b>\"We still really like this stock.\"</b></p>\n<p>In February,<b>Piper Sandler</b>&nbsp;analyst Alexander Pottermade a bold call, boosting his 12-month price target for thegrowth stockfrom $515 to $1,200. He said Tesla deliveries could increase from 500,000 vehicles in 2020 to nearly 900,000 this year. Of course, this projection was made before global supply shortages worsened. Nevertheless, Tesla is growing extremely rapidly. The company's second-quarter deliveries more than doubled compared to the year-ago quarter, rising to 201,304.</p>\n<p>Following Tesla's second-quarter earnings release late last month, the analyst reiterated this target, noting that the company looks poised to benefit from market share gains, the monetization of the company's Autopilot software, and \"underappreciated opportunities\" in Tesla's energy business, which includes revenue from battery energy storage and solar energy generation products.</p>\n<p>Further, Potter pointed to Tesla's strong second-quarter operating margin of 11%, which he expects will see incremental improvement from Tesla's recently launched Autopilot subscription.</p>\n<p>On Aug. 3, Potter once again reiterated an overweight rating on the stock and a $1,200 price target, saying \"We still really like this stock.\" He pointed to growing demand for battery electric vehicles overall.</p>\n<p><b>So what gives?</b></p>\n<p>If shares could truly rise to $1,200, why do so many investors seem to think the stock is worth so much less (based on the stock's price of just under $700 at the time of this writing). After all, if $1,200 was generally viewed by investors as a likely outcome for Tesla stock within the next 12 months, shares would be trading significantly higher today.</p>\n<p>The issue boils down to the stock's forward-looking valuation. With a price-to-earnings ratio of about 370 at the time of this writing, Tesla shares are largely priced for strong growth for years to come. Since the company's valuation is based largely on profits far into the future, slight variances in views for Tesla's future growth trajectory yield dramatically different assumptions about the stock's intrinsic value today.</p>\n<p>Investors, therefore, shouldn't be quick to buy Tesla stock just because one analyst has a high price target for shares. Still, Potter does notably have some good points about Tesla's strong business momentum. Even Tesla itself reiterated guidance for vehicle deliveries to grow more than 50% this year -- and that guidance was provided during a time that many companies around the world (including Tesla) are negatively impacted by supply chain shortages. Further, Tesla management noted in its second-quarter update that demand for its vehicles was at an all-time high going into Q3.</p>\n<p>While a $1,200 price target for Tesla stock would be difficult to justify, shares may be trading low enough for investors to start a small position in the stock.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock: Headed to $1,200?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock: Headed to $1,200?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-08 09:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/07/tesla-stock-headed-to-1200/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nTesla deliveries more than doubled year over year in Q2.\nRising demand for electric vehicles could benefit Tesla.\nInvestors should exercise caution when it comes to analysts' price targets...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/07/tesla-stock-headed-to-1200/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/08/07/tesla-stock-headed-to-1200/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159872041","content_text":"Key Points\n\nTesla deliveries more than doubled year over year in Q2.\nRising demand for electric vehicles could benefit Tesla.\nInvestors should exercise caution when it comes to analysts' price targets.\n\nIt's been a wild year for Tesla(NASDAQ:TSLA)stock. When the year started, shares initially surged more than 20%. But the stock has now given up all of those gains, with a year-to-date return of negative 1%. This means the stock has significantly underperformed the S&P 500's 18% gain this year.\nBut one analyst thinks the stock could take off.\n\"We still really like this stock.\"\nIn February,Piper Sandler analyst Alexander Pottermade a bold call, boosting his 12-month price target for thegrowth stockfrom $515 to $1,200. He said Tesla deliveries could increase from 500,000 vehicles in 2020 to nearly 900,000 this year. Of course, this projection was made before global supply shortages worsened. Nevertheless, Tesla is growing extremely rapidly. The company's second-quarter deliveries more than doubled compared to the year-ago quarter, rising to 201,304.\nFollowing Tesla's second-quarter earnings release late last month, the analyst reiterated this target, noting that the company looks poised to benefit from market share gains, the monetization of the company's Autopilot software, and \"underappreciated opportunities\" in Tesla's energy business, which includes revenue from battery energy storage and solar energy generation products.\nFurther, Potter pointed to Tesla's strong second-quarter operating margin of 11%, which he expects will see incremental improvement from Tesla's recently launched Autopilot subscription.\nOn Aug. 3, Potter once again reiterated an overweight rating on the stock and a $1,200 price target, saying \"We still really like this stock.\" He pointed to growing demand for battery electric vehicles overall.\nSo what gives?\nIf shares could truly rise to $1,200, why do so many investors seem to think the stock is worth so much less (based on the stock's price of just under $700 at the time of this writing). After all, if $1,200 was generally viewed by investors as a likely outcome for Tesla stock within the next 12 months, shares would be trading significantly higher today.\nThe issue boils down to the stock's forward-looking valuation. With a price-to-earnings ratio of about 370 at the time of this writing, Tesla shares are largely priced for strong growth for years to come. Since the company's valuation is based largely on profits far into the future, slight variances in views for Tesla's future growth trajectory yield dramatically different assumptions about the stock's intrinsic value today.\nInvestors, therefore, shouldn't be quick to buy Tesla stock just because one analyst has a high price target for shares. Still, Potter does notably have some good points about Tesla's strong business momentum. Even Tesla itself reiterated guidance for vehicle deliveries to grow more than 50% this year -- and that guidance was provided during a time that many companies around the world (including Tesla) are negatively impacted by supply chain shortages. Further, Tesla management noted in its second-quarter update that demand for its vehicles was at an all-time high going into Q3.\nWhile a $1,200 price target for Tesla stock would be difficult to justify, shares may be trading low enough for investors to start a small position in the stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893269942,"gmtCreate":1628265017386,"gmtModify":1703504323424,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Commented on this&nbsp;","listText":"Commented on this&nbsp;","text":"Commented on this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/893269942","repostId":"1159359820","repostType":4,"repost":{"id":"1159359820","kind":"news","pubTimestamp":1628264299,"share":"https://ttm.financial/m/news/1159359820?lang=&edition=fundamental","pubTime":"2021-08-06 23:38","market":"us","language":"en","title":"Space Race, Nasdaq, IBM, Nvidia: What to Watch When the Stock Market Opens","url":"https://stock-news.laohu8.com/highlight/detail?id=1159359820","media":"The Wall Street Journal","summary":"Stock futures are higher after Monday’s slide on Wall Street.\n\n\nTo the moon! Well, not quite, butint","content":"<blockquote>\n <b>Stock futures are higher after Monday’s slide on Wall Street.</b>\n</blockquote>\n<p></p>\n<p>To the moon! Well, not quite, butinto space at leasttoday forJeff Bezos,the billionaire baron of ecommerce. Also not going to the moon isAmazonAMZN-1.19%stock, though it is 0.3% up premarket on Tuesday morning.</p>\n<ul>\n <li>One reason for Mr. Bezos’s rocket ride is the more earthly goal of winning government contracts for the kind of less thrilling scientific projects the provide reliable revenue. His Blue Origin company is playing catch-up withElon Musk’s SpaceX.</li>\n <li>Mr. Musk’s electric vehicle makerTesla,TSLA-1.55%is getting a bit of a boost Tuesday morning ahead of the open, rising 1% premarket. It is also gaining more attention on the message boards among day traders, according to Topstonks.com. The company reports earnings next Monday and tends to see its stock rise in the days ahead as investors start hoping for exciting announcements.</li>\n <li>In the wider markets, U.S. stock futures are trending higher ahead of the open following Monday’s broad selloff. S&amp;P 500 futures and Dow futures are up 0.3%, and Nasdaq-100 futures are up 0.4%.</li>\n <li>Nasdaq the company, not the index, is itself rising premarket, up 1%, after TheWall Street Journal’s exclusivethat it will spin out its Private Market for shares in start-ups that trade among some investors before an initial public offering. The business will go into a standalone joint venture company and get investment from three Wall Street banks and SVB Financial Group, a tech specialist bank.</li>\n <li>NvidiaNVDA-1.30%is down 0.8% on large volumes following a &nbsp;3.4% rise Monday. The shares are up nearly 80% over the past year, putting the chip makerinto the top 10list of U.S. public companies. It also executed its four-for-one stock split overnight, which has given some investorsmore ways to trade the stock-performance.</li>\n <li>International Business MachinesIBM+0.54%is up 2.8% ahead of the open on Tuesday after turning in decent second-quarter numbers Monday after the close. The computing group’s efforts to refocus on cloud-based computing and spin off its old-fashioned IT services business is winning fans among investors. At the same time, it has benefitted from companies beginning to invest again as the economy reopens.</li>\n</ul>\n<ul>\n <li>Advanced Micro DevicesAMD+1.43%is rising up the chat charts on social media platforms, according to Topstonks.com, gaining popularity among retail traders. Its shares are up 0.4% premarket on good volumes following a 0.8% rise Monday.</li>\n <li>Growing chatter and chunky volumes Tuesday morning for another perennial retail favourite:AMC Entertainment.AMC-3.16%The cinema chain’s shares have taken a bit of a beating so far this month, but they are 1.7% higher premarket Tuesday.</li>\n <li>Zoom Video CommunicationsZM-3.50%is bouncing slightly Tuesday morning, up 0.4% in premarket trading after a 2.2% drop on Monday when it revealed it would buy customer service software firmFive9.FIVN-3.04%The target’s shares jumped nearly 6% Monday, are down 0.3% premarket.</li>\n <li>Shares in big U.S. investments banks, which all took a knock Monday with the drop in financial markets, look set to rebound a bit Tuesday:Goldman SachsGS+2.91%andJPMorgan ChaseJPM+2.66%are both up about 0.3%, while andMorgan StanleyMS+1.64%up about 0.5% in premarket trading.</li>\n <li>Bitcoin dropped below $30,000 Tuesday for the first time in a month.</li>\n <li>Netflix,NFLX-0.33%United AirlinesUAL-0.71%andChipotle Mexican GrillCMG-0.63%are due to report earnings after Tuesday’s close.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/6454f89ce9900ecbca7664b0da4ff6fa\" tg-width=\"761\" tg-height=\"567\" width=\"100%\" height=\"auto\"></p>\n<ul>\n <li>Stocks, commodities and other financial marketstook a stumbleMonday on growing concerns about the strength of the post-Covid-19 global recovery.</li>\n</ul>\n<p><b>Corrections &amp; Amplifications</b></p>\n<p>Nvidia shares rose 3.4% on Monday,&nbsp;July 19. An earlier version of this article incorrectly&nbsp;said that they rose 15%. A separate version of the article incorrectly said they rose 3%. (Corrected on Aug. 6)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Space Race, Nasdaq, IBM, Nvidia: What to Watch When the Stock Market Opens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSpace Race, Nasdaq, IBM, Nvidia: What to Watch When the Stock Market Opens\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-06 23:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/space-race-nvidia-and-ibm-what-to-watch-when-the-market-opens-11626778707?mod=rss_markets_main><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock futures are higher after Monday’s slide on Wall Street.\n\n\nTo the moon! Well, not quite, butinto space at leasttoday forJeff Bezos,the billionaire baron of ecommerce. Also not going to the moon ...</p>\n\n<a href=\"https://www.wsj.com/articles/space-race-nvidia-and-ibm-what-to-watch-when-the-market-opens-11626778707?mod=rss_markets_main\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.wsj.com/articles/space-race-nvidia-and-ibm-what-to-watch-when-the-market-opens-11626778707?mod=rss_markets_main","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159359820","content_text":"Stock futures are higher after Monday’s slide on Wall Street.\n\n\nTo the moon! Well, not quite, butinto space at leasttoday forJeff Bezos,the billionaire baron of ecommerce. Also not going to the moon isAmazonAMZN-1.19%stock, though it is 0.3% up premarket on Tuesday morning.\n\nOne reason for Mr. Bezos’s rocket ride is the more earthly goal of winning government contracts for the kind of less thrilling scientific projects the provide reliable revenue. His Blue Origin company is playing catch-up withElon Musk’s SpaceX.\nMr. Musk’s electric vehicle makerTesla,TSLA-1.55%is getting a bit of a boost Tuesday morning ahead of the open, rising 1% premarket. It is also gaining more attention on the message boards among day traders, according to Topstonks.com. The company reports earnings next Monday and tends to see its stock rise in the days ahead as investors start hoping for exciting announcements.\nIn the wider markets, U.S. stock futures are trending higher ahead of the open following Monday’s broad selloff. S&P 500 futures and Dow futures are up 0.3%, and Nasdaq-100 futures are up 0.4%.\nNasdaq the company, not the index, is itself rising premarket, up 1%, after TheWall Street Journal’s exclusivethat it will spin out its Private Market for shares in start-ups that trade among some investors before an initial public offering. The business will go into a standalone joint venture company and get investment from three Wall Street banks and SVB Financial Group, a tech specialist bank.\nNvidiaNVDA-1.30%is down 0.8% on large volumes following a  3.4% rise Monday. The shares are up nearly 80% over the past year, putting the chip makerinto the top 10list of U.S. public companies. It also executed its four-for-one stock split overnight, which has given some investorsmore ways to trade the stock-performance.\nInternational Business MachinesIBM+0.54%is up 2.8% ahead of the open on Tuesday after turning in decent second-quarter numbers Monday after the close. The computing group’s efforts to refocus on cloud-based computing and spin off its old-fashioned IT services business is winning fans among investors. At the same time, it has benefitted from companies beginning to invest again as the economy reopens.\n\n\nAdvanced Micro DevicesAMD+1.43%is rising up the chat charts on social media platforms, according to Topstonks.com, gaining popularity among retail traders. Its shares are up 0.4% premarket on good volumes following a 0.8% rise Monday.\nGrowing chatter and chunky volumes Tuesday morning for another perennial retail favourite:AMC Entertainment.AMC-3.16%The cinema chain’s shares have taken a bit of a beating so far this month, but they are 1.7% higher premarket Tuesday.\nZoom Video CommunicationsZM-3.50%is bouncing slightly Tuesday morning, up 0.4% in premarket trading after a 2.2% drop on Monday when it revealed it would buy customer service software firmFive9.FIVN-3.04%The target’s shares jumped nearly 6% Monday, are down 0.3% premarket.\nShares in big U.S. investments banks, which all took a knock Monday with the drop in financial markets, look set to rebound a bit Tuesday:Goldman SachsGS+2.91%andJPMorgan ChaseJPM+2.66%are both up about 0.3%, while andMorgan StanleyMS+1.64%up about 0.5% in premarket trading.\nBitcoin dropped below $30,000 Tuesday for the first time in a month.\nNetflix,NFLX-0.33%United AirlinesUAL-0.71%andChipotle Mexican GrillCMG-0.63%are due to report earnings after Tuesday’s close.\n\n\n\nStocks, commodities and other financial marketstook a stumbleMonday on growing concerns about the strength of the post-Covid-19 global recovery.\n\nCorrections & Amplifications\nNvidia shares rose 3.4% on Monday, July 19. An earlier version of this article incorrectly said that they rose 15%. A separate version of the article incorrectly said they rose 3%. (Corrected on Aug. 6)","news_type":1},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893377344,"gmtCreate":1628242147288,"gmtModify":1703503818589,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/893377344","repostId":"2157432677","repostType":4,"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899108156,"gmtCreate":1628166151775,"gmtModify":1703502392402,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Like me please","listText":"Like me please","text":"Like me please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899108156","repostId":"2157015435","repostType":4,"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899101279,"gmtCreate":1628166081291,"gmtModify":1703502391433,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899101279","repostId":"2157395984","repostType":4,"repost":{"id":"2157395984","kind":"highlight","pubTimestamp":1628165160,"share":"https://ttm.financial/m/news/2157395984?lang=&edition=fundamental","pubTime":"2021-08-05 20:06","market":"us","language":"en","title":"Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2157395984","media":"Motley Fool","summary":"Projecting over $33 billion in COVID-19 vaccine revenue alone in 2021, CEO Albert Bourla wants to beef up Pfizer's pipeline.","content":"<p>Speaking back in May on his company's Q1 2021 earnings call, <b>Pfizer</b> (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] ... in the second part of the decade.\" &nbsp;With pre-tax profit on its COVID-19 vaccine in the high 20% range and Bourla's company guiding for $78 billion to $80 billion in revenue for 2021 (with more than $33 billion of that coming from the vaccine), there's certainly money to be spent on acquisitions. Let's look at three potential candidates that could help Pfizer to further secure its future.</p>\n<h3>The budding oncology research machine</h3>\n<p>If Pfizer wants to fill its pipeline with precision-medicine oncology drugs for the next decade, perhaps it will consider <b>Blueprint Medicines</b> (NASDAQ:BPMC). This $5 billion biotech is the first and only company to have two internally discovered and developed medicines that received U.S. Food and Drug Administration (FDA) approval within a decade of its founding.</p>\n<p><img src=\"https://static.tigerbbs.com/0cba561a33b8fd037c17212c807d1ccb\" tg-width=\"700\" tg-height=\"438\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>Its first oncology drug, Gavreto, is a once-a-day oral medication for non-small cell lung cancer, as well as certain types of thyroid cancer with a mutation in a specific gene called RET. Altogether, these markets add up to about 6,000 patients annually in the U.S.</p>\n<p>At a cost of $231,000 per patient per year, that's a $1.3 billion addressable market for which Blueprint and partner <b>Roche</b> will split costs and profits 50-50 in the U.S. While Gavreto competes with <b>Eli Lilly</b>'s&nbsp;Retevmo in this market, the Roche-Blueprint product currently has a 40% share of the RET-inhibitor space, despite being the second <a href=\"https://laohu8.com/S/AONE.U\">one</a> to the party.</p>\n<p>The precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. <b>AstraZeneca</b>'s Tagrisso, which has a similar target, hauled in a whopping $4.3 billion-plus in FY 2020.</p>\n<p>While there is some tough competition out there, Blueprint has shown it can quickly bring drugs to market. With plenty of financial support and a large seasoned sales force already in place, Pfizer could rapidly capitalize on a buyout of this $5 billion business. And we haven't even mentioned Blueprint's other approved drug, which is for a rare disease called mastocytosis&nbsp;and has an addressable market in the U.S. of at least $800 million.</p>\n<h3>The safe rare-disease tuck-in</h3>\n<p>When<b> Aurinia Pharmaceuticals</b>' (NASDAQ:AUPH) Lupkynis was approved in January, it became the first oral therapy approved for lupus nephritis that doesn't require monitoring of drug levels. Lupus nephritis is an autoimmune disorder that's especially harsh on the kidneys, with approximately 10% to 30% of patients experiencing kidney failure within 15 years, despite current therapies.</p>\n<p>This disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likely&nbsp;to improve kidney function. In fact, 40.8% of patients see improvements in renal function after 52 treatments with Lupkynis, versus 22.5% receiving standard-of-care treatment alone.</p>\n<p>The autoimmune-focused biotech expects an average annualized net revenue per patient of approximately $65,000. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion.</p>\n<p>Even better, this doesn't even get into the potential for Lupkynis to treat other autoimmune diseases. Pfizer already has multiple compounds aimed at various autoimmune conditions, and this $1.8 billion company seems like an obvious tuck-in acquisition for the pharma giant. It has an approved drug with a blockbuster addressable market, and that drug may have optionality for other autoimmune conditions as well (though it's not actively being studied in other diseases at the moment).</p>\n<h3>The next frontier in COVID treatment</h3>\n<p>With COVID-19 cases rising worldwide, there's a pressing need for an efficacious oral therapy that can be administered not only to hospitalized patients but also to those well enough to be given a prescription as outpatients. Pharma <b>Atea Pharmaceuticals</b> (NASDAQ:AVIR)&nbsp;reported interim phase 2 results at the end of June showing that its lead COVID-19 oral treatment, AT-527, could rapidly reduce the viral load in COVID-19 patients.</p>\n<p>After two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. Atea partnered with Roche in October 2020 on AT-527, and the drug is now in an ongoing worldwide phase 3 trial with results due in the second half of 2021. After its raging success with <b>BioNTech </b>on their coronavirus vaccine, Pfizer may be willing to double down on partnerships in the COVID-19 space -- especially with Bourla's company raising its 2021 sales forecast of its partnered COVID-19 vaccine to $33.5 billion for the year.</p>\n<p>With Atea valued at just $2.1 billion yet having megablockbuster potential, there's a lot of upside for Pfizer. An Atea buyout also would provide a safety net should Pfizer's own oral combination therapy for COVID, which just entered phase 2/3 trials, fizzle out.</p>\n<p>If I were Albert Bourla, which would I choose? On July 22, Pfizer announced a global collaboration with Arvinas, which has a breast cancer treatment in phase 2 trials. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. Given this, the behemoth may not be looking for another oncology company right away. And despite impressive COVID-19 data from Atea, Pfizer has its own oral coronavirus treatment early in progress, though not quite as far along in clinical trials.</p>\n<p>That leaves Aurinia, which I believe to be the safest buy on the list for pharmaceutical investors -- Pfizer included. With a market cap of less than $2 billion and a potential blockbuster that has possible optionality into other autoimmune diseases, Aurinia looks undervalued and could find itself being acquired sooner rather than later.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-05 20:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Speaking back in May on his company's Q1 2021 earnings call, Pfizer (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157395984","content_text":"Speaking back in May on his company's Q1 2021 earnings call, Pfizer (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] ... in the second part of the decade.\"  With pre-tax profit on its COVID-19 vaccine in the high 20% range and Bourla's company guiding for $78 billion to $80 billion in revenue for 2021 (with more than $33 billion of that coming from the vaccine), there's certainly money to be spent on acquisitions. Let's look at three potential candidates that could help Pfizer to further secure its future.\nThe budding oncology research machine\nIf Pfizer wants to fill its pipeline with precision-medicine oncology drugs for the next decade, perhaps it will consider Blueprint Medicines (NASDAQ:BPMC). This $5 billion biotech is the first and only company to have two internally discovered and developed medicines that received U.S. Food and Drug Administration (FDA) approval within a decade of its founding.\n\nImage source: Getty Images.\nIts first oncology drug, Gavreto, is a once-a-day oral medication for non-small cell lung cancer, as well as certain types of thyroid cancer with a mutation in a specific gene called RET. Altogether, these markets add up to about 6,000 patients annually in the U.S.\nAt a cost of $231,000 per patient per year, that's a $1.3 billion addressable market for which Blueprint and partner Roche will split costs and profits 50-50 in the U.S. While Gavreto competes with Eli Lilly's Retevmo in this market, the Roche-Blueprint product currently has a 40% share of the RET-inhibitor space, despite being the second one to the party.\nThe precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. AstraZeneca's Tagrisso, which has a similar target, hauled in a whopping $4.3 billion-plus in FY 2020.\nWhile there is some tough competition out there, Blueprint has shown it can quickly bring drugs to market. With plenty of financial support and a large seasoned sales force already in place, Pfizer could rapidly capitalize on a buyout of this $5 billion business. And we haven't even mentioned Blueprint's other approved drug, which is for a rare disease called mastocytosis and has an addressable market in the U.S. of at least $800 million.\nThe safe rare-disease tuck-in\nWhen Aurinia Pharmaceuticals' (NASDAQ:AUPH) Lupkynis was approved in January, it became the first oral therapy approved for lupus nephritis that doesn't require monitoring of drug levels. Lupus nephritis is an autoimmune disorder that's especially harsh on the kidneys, with approximately 10% to 30% of patients experiencing kidney failure within 15 years, despite current therapies.\nThis disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likely to improve kidney function. In fact, 40.8% of patients see improvements in renal function after 52 treatments with Lupkynis, versus 22.5% receiving standard-of-care treatment alone.\nThe autoimmune-focused biotech expects an average annualized net revenue per patient of approximately $65,000. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion.\nEven better, this doesn't even get into the potential for Lupkynis to treat other autoimmune diseases. Pfizer already has multiple compounds aimed at various autoimmune conditions, and this $1.8 billion company seems like an obvious tuck-in acquisition for the pharma giant. It has an approved drug with a blockbuster addressable market, and that drug may have optionality for other autoimmune conditions as well (though it's not actively being studied in other diseases at the moment).\nThe next frontier in COVID treatment\nWith COVID-19 cases rising worldwide, there's a pressing need for an efficacious oral therapy that can be administered not only to hospitalized patients but also to those well enough to be given a prescription as outpatients. Pharma Atea Pharmaceuticals (NASDAQ:AVIR) reported interim phase 2 results at the end of June showing that its lead COVID-19 oral treatment, AT-527, could rapidly reduce the viral load in COVID-19 patients.\nAfter two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. Atea partnered with Roche in October 2020 on AT-527, and the drug is now in an ongoing worldwide phase 3 trial with results due in the second half of 2021. After its raging success with BioNTech on their coronavirus vaccine, Pfizer may be willing to double down on partnerships in the COVID-19 space -- especially with Bourla's company raising its 2021 sales forecast of its partnered COVID-19 vaccine to $33.5 billion for the year.\nWith Atea valued at just $2.1 billion yet having megablockbuster potential, there's a lot of upside for Pfizer. An Atea buyout also would provide a safety net should Pfizer's own oral combination therapy for COVID, which just entered phase 2/3 trials, fizzle out.\nIf I were Albert Bourla, which would I choose? On July 22, Pfizer announced a global collaboration with Arvinas, which has a breast cancer treatment in phase 2 trials. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. Given this, the behemoth may not be looking for another oncology company right away. And despite impressive COVID-19 data from Atea, Pfizer has its own oral coronavirus treatment early in progress, though not quite as far along in clinical trials.\nThat leaves Aurinia, which I believe to be the safest buy on the list for pharmaceutical investors -- Pfizer included. With a market cap of less than $2 billion and a potential blockbuster that has possible optionality into other autoimmune diseases, Aurinia looks undervalued and could find itself being acquired sooner rather than later.","news_type":1},"isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899101825,"gmtCreate":1628166054467,"gmtModify":1703502391594,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899101825","repostId":"2157395984","repostType":4,"repost":{"id":"2157395984","kind":"highlight","pubTimestamp":1628165160,"share":"https://ttm.financial/m/news/2157395984?lang=&edition=fundamental","pubTime":"2021-08-05 20:06","market":"us","language":"en","title":"Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2157395984","media":"Motley Fool","summary":"Projecting over $33 billion in COVID-19 vaccine revenue alone in 2021, CEO Albert Bourla wants to beef up Pfizer's pipeline.","content":"<p>Speaking back in May on his company's Q1 2021 earnings call, <b>Pfizer</b> (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] ... in the second part of the decade.\" &nbsp;With pre-tax profit on its COVID-19 vaccine in the high 20% range and Bourla's company guiding for $78 billion to $80 billion in revenue for 2021 (with more than $33 billion of that coming from the vaccine), there's certainly money to be spent on acquisitions. Let's look at three potential candidates that could help Pfizer to further secure its future.</p>\n<h3>The budding oncology research machine</h3>\n<p>If Pfizer wants to fill its pipeline with precision-medicine oncology drugs for the next decade, perhaps it will consider <b>Blueprint Medicines</b> (NASDAQ:BPMC). This $5 billion biotech is the first and only company to have two internally discovered and developed medicines that received U.S. Food and Drug Administration (FDA) approval within a decade of its founding.</p>\n<p><img src=\"https://static.tigerbbs.com/0cba561a33b8fd037c17212c807d1ccb\" tg-width=\"700\" tg-height=\"438\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>Its first oncology drug, Gavreto, is a once-a-day oral medication for non-small cell lung cancer, as well as certain types of thyroid cancer with a mutation in a specific gene called RET. Altogether, these markets add up to about 6,000 patients annually in the U.S.</p>\n<p>At a cost of $231,000 per patient per year, that's a $1.3 billion addressable market for which Blueprint and partner <b>Roche</b> will split costs and profits 50-50 in the U.S. While Gavreto competes with <b>Eli Lilly</b>'s&nbsp;Retevmo in this market, the Roche-Blueprint product currently has a 40% share of the RET-inhibitor space, despite being the second <a href=\"https://laohu8.com/S/AONE.U\">one</a> to the party.</p>\n<p>The precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. <b>AstraZeneca</b>'s Tagrisso, which has a similar target, hauled in a whopping $4.3 billion-plus in FY 2020.</p>\n<p>While there is some tough competition out there, Blueprint has shown it can quickly bring drugs to market. With plenty of financial support and a large seasoned sales force already in place, Pfizer could rapidly capitalize on a buyout of this $5 billion business. And we haven't even mentioned Blueprint's other approved drug, which is for a rare disease called mastocytosis&nbsp;and has an addressable market in the U.S. of at least $800 million.</p>\n<h3>The safe rare-disease tuck-in</h3>\n<p>When<b> Aurinia Pharmaceuticals</b>' (NASDAQ:AUPH) Lupkynis was approved in January, it became the first oral therapy approved for lupus nephritis that doesn't require monitoring of drug levels. Lupus nephritis is an autoimmune disorder that's especially harsh on the kidneys, with approximately 10% to 30% of patients experiencing kidney failure within 15 years, despite current therapies.</p>\n<p>This disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likely&nbsp;to improve kidney function. In fact, 40.8% of patients see improvements in renal function after 52 treatments with Lupkynis, versus 22.5% receiving standard-of-care treatment alone.</p>\n<p>The autoimmune-focused biotech expects an average annualized net revenue per patient of approximately $65,000. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion.</p>\n<p>Even better, this doesn't even get into the potential for Lupkynis to treat other autoimmune diseases. Pfizer already has multiple compounds aimed at various autoimmune conditions, and this $1.8 billion company seems like an obvious tuck-in acquisition for the pharma giant. It has an approved drug with a blockbuster addressable market, and that drug may have optionality for other autoimmune conditions as well (though it's not actively being studied in other diseases at the moment).</p>\n<h3>The next frontier in COVID treatment</h3>\n<p>With COVID-19 cases rising worldwide, there's a pressing need for an efficacious oral therapy that can be administered not only to hospitalized patients but also to those well enough to be given a prescription as outpatients. Pharma <b>Atea Pharmaceuticals</b> (NASDAQ:AVIR)&nbsp;reported interim phase 2 results at the end of June showing that its lead COVID-19 oral treatment, AT-527, could rapidly reduce the viral load in COVID-19 patients.</p>\n<p>After two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. Atea partnered with Roche in October 2020 on AT-527, and the drug is now in an ongoing worldwide phase 3 trial with results due in the second half of 2021. After its raging success with <b>BioNTech </b>on their coronavirus vaccine, Pfizer may be willing to double down on partnerships in the COVID-19 space -- especially with Bourla's company raising its 2021 sales forecast of its partnered COVID-19 vaccine to $33.5 billion for the year.</p>\n<p>With Atea valued at just $2.1 billion yet having megablockbuster potential, there's a lot of upside for Pfizer. An Atea buyout also would provide a safety net should Pfizer's own oral combination therapy for COVID, which just entered phase 2/3 trials, fizzle out.</p>\n<p>If I were Albert Bourla, which would I choose? On July 22, Pfizer announced a global collaboration with Arvinas, which has a breast cancer treatment in phase 2 trials. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. Given this, the behemoth may not be looking for another oncology company right away. And despite impressive COVID-19 data from Atea, Pfizer has its own oral coronavirus treatment early in progress, though not quite as far along in clinical trials.</p>\n<p>That leaves Aurinia, which I believe to be the safest buy on the list for pharmaceutical investors -- Pfizer included. With a market cap of less than $2 billion and a potential blockbuster that has possible optionality into other autoimmune diseases, Aurinia looks undervalued and could find itself being acquired sooner rather than later.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-05 20:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Speaking back in May on his company's Q1 2021 earnings call, Pfizer (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157395984","content_text":"Speaking back in May on his company's Q1 2021 earnings call, Pfizer (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] ... in the second part of the decade.\"  With pre-tax profit on its COVID-19 vaccine in the high 20% range and Bourla's company guiding for $78 billion to $80 billion in revenue for 2021 (with more than $33 billion of that coming from the vaccine), there's certainly money to be spent on acquisitions. Let's look at three potential candidates that could help Pfizer to further secure its future.\nThe budding oncology research machine\nIf Pfizer wants to fill its pipeline with precision-medicine oncology drugs for the next decade, perhaps it will consider Blueprint Medicines (NASDAQ:BPMC). This $5 billion biotech is the first and only company to have two internally discovered and developed medicines that received U.S. Food and Drug Administration (FDA) approval within a decade of its founding.\n\nImage source: Getty Images.\nIts first oncology drug, Gavreto, is a once-a-day oral medication for non-small cell lung cancer, as well as certain types of thyroid cancer with a mutation in a specific gene called RET. Altogether, these markets add up to about 6,000 patients annually in the U.S.\nAt a cost of $231,000 per patient per year, that's a $1.3 billion addressable market for which Blueprint and partner Roche will split costs and profits 50-50 in the U.S. While Gavreto competes with Eli Lilly's Retevmo in this market, the Roche-Blueprint product currently has a 40% share of the RET-inhibitor space, despite being the second one to the party.\nThe precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. AstraZeneca's Tagrisso, which has a similar target, hauled in a whopping $4.3 billion-plus in FY 2020.\nWhile there is some tough competition out there, Blueprint has shown it can quickly bring drugs to market. With plenty of financial support and a large seasoned sales force already in place, Pfizer could rapidly capitalize on a buyout of this $5 billion business. And we haven't even mentioned Blueprint's other approved drug, which is for a rare disease called mastocytosis and has an addressable market in the U.S. of at least $800 million.\nThe safe rare-disease tuck-in\nWhen Aurinia Pharmaceuticals' (NASDAQ:AUPH) Lupkynis was approved in January, it became the first oral therapy approved for lupus nephritis that doesn't require monitoring of drug levels. Lupus nephritis is an autoimmune disorder that's especially harsh on the kidneys, with approximately 10% to 30% of patients experiencing kidney failure within 15 years, despite current therapies.\nThis disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likely to improve kidney function. In fact, 40.8% of patients see improvements in renal function after 52 treatments with Lupkynis, versus 22.5% receiving standard-of-care treatment alone.\nThe autoimmune-focused biotech expects an average annualized net revenue per patient of approximately $65,000. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion.\nEven better, this doesn't even get into the potential for Lupkynis to treat other autoimmune diseases. Pfizer already has multiple compounds aimed at various autoimmune conditions, and this $1.8 billion company seems like an obvious tuck-in acquisition for the pharma giant. It has an approved drug with a blockbuster addressable market, and that drug may have optionality for other autoimmune conditions as well (though it's not actively being studied in other diseases at the moment).\nThe next frontier in COVID treatment\nWith COVID-19 cases rising worldwide, there's a pressing need for an efficacious oral therapy that can be administered not only to hospitalized patients but also to those well enough to be given a prescription as outpatients. Pharma Atea Pharmaceuticals (NASDAQ:AVIR) reported interim phase 2 results at the end of June showing that its lead COVID-19 oral treatment, AT-527, could rapidly reduce the viral load in COVID-19 patients.\nAfter two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. Atea partnered with Roche in October 2020 on AT-527, and the drug is now in an ongoing worldwide phase 3 trial with results due in the second half of 2021. After its raging success with BioNTech on their coronavirus vaccine, Pfizer may be willing to double down on partnerships in the COVID-19 space -- especially with Bourla's company raising its 2021 sales forecast of its partnered COVID-19 vaccine to $33.5 billion for the year.\nWith Atea valued at just $2.1 billion yet having megablockbuster potential, there's a lot of upside for Pfizer. An Atea buyout also would provide a safety net should Pfizer's own oral combination therapy for COVID, which just entered phase 2/3 trials, fizzle out.\nIf I were Albert Bourla, which would I choose? On July 22, Pfizer announced a global collaboration with Arvinas, which has a breast cancer treatment in phase 2 trials. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. Given this, the behemoth may not be looking for another oncology company right away. And despite impressive COVID-19 data from Atea, Pfizer has its own oral coronavirus treatment early in progress, though not quite as far along in clinical trials.\nThat leaves Aurinia, which I believe to be the safest buy on the list for pharmaceutical investors -- Pfizer included. With a market cap of less than $2 billion and a potential blockbuster that has possible optionality into other autoimmune diseases, Aurinia looks undervalued and could find itself being acquired sooner rather than later.","news_type":1},"isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807734157,"gmtCreate":1628056708179,"gmtModify":1703500411771,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/807734157","repostId":"1177585640","repostType":4,"repost":{"id":"1177585640","kind":"news","pubTimestamp":1628056440,"share":"https://ttm.financial/m/news/1177585640?lang=&edition=fundamental","pubTime":"2021-08-04 13:54","market":"us","language":"en","title":"Why Clean Energy Fuels Has Plenty of Work To Do","url":"https://stock-news.laohu8.com/highlight/detail?id=1177585640","media":"InvestorPlace","summary":"Clean Energy Fuels history of low to zero margins will keep the stock down unless they turn things a","content":"<p>Clean Energy Fuels history of low to zero margins will keep the stock down unless they turn things around</p>\n<p>Yes, it’s possible to invest in cow poo — or at least the product that is derived from it. Renewable natural gas (RNG) is a transportation fuel made from organic waste, primarily from cattle. Once it’s purified, this biomethane is chemically identical to the main ingredient in the fossil-based natural gas that comes out of a stove or heats residential water. The use of RNGs drastically reduces carbon emissions, and unlike conventional natural gas, RNG is not a fossil fuel and does not involve drilling. That said, the leader in this sector is&nbsp;<b>Clean Energy Fuels</b>(NASDAQ:<b><u>CLNE</u></b>) — but CLNE stock may lose its one-year gains of the firm doesn’t figure things out.</p>\n<p>Overall, Clean Energy Fuels provides natural gas as an alternative fuel for vehicle fleets and related fueling solutions, primarily in the United States and Canada. It supplies RNG, compressed natural gas (CNG) and liquefied natural gas (LNG) for light, medium, and heavy-duty vehicles. Additionally, the company offers operation and maintenance services for public and private vehicle fleet customer stations.</p>\n<p>Moreover, the company also designs, builds, operates and maintains fueling stations. It also sells and services compressors and other equipment that are used in fueling stations, and provides assessment, design and modification solutions to offer operators with code-compliant service and maintenance facilities for natural gas vehicle fleets.</p>\n<p>Collectively, Clean Energy Fuels serves heavy-duty trucking, airports, refuse, public transit, industrial, and institutional energy users, as well as government fleets. As of December 31, 2020, it served approximately&nbsp;1,000 fleet customers&nbsp;operating approximately 48,000 vehicles. And it also owned, operated, or supplied approximately 565 fueling stations in 39 states in the United States and five provinces in Canada.</p>\n<p>The Opportunity and Benefit of Clean Energy</p>\n<p>According to the company, livestock manure and landfills account for 27% of methane emissions in the U.S. That said, this is the original source of where Clean Energy Fuels gets its RNG.</p>\n<p>When organic matter decays, it naturally produces methane — one of the greenhouse gases most detrimental to the environment. So, by capturing the methane, the company prevents it from entering and damaging the atmosphere. Then, they can then turn it into clean fuel for the transportation industry. That said, the transportation industry — as a whole — was responsible for&nbsp;29% of the total greenhouse gas emissions in the U.S.&nbsp;in 2019.</p>\n<p>This all sounds great, so there must be a catch. Well, the catch is that Clean Energy Fuels has been around a very long time, but still cant generate consistent high margin profits. That said, here is a very-detailed explanation of why the company is struggling in that department:</p>\n<blockquote>\n “…The only logical explanation is that Clean Energy&nbsp;owns a very small percentage&nbsp;of the 540 fueling stations spread across the USA. It operates, maintains and supplies the fueling station with natural gases at commodity prices plus charges for transportation, compression, storage and maintenance. While Clean Energy has adopted an excellent business model, unfortunately, it operates in an area of the value chain with minimal operating margins.”\n</blockquote>\n<blockquote>\n “Over the past five years, Clean Energy Fuels has consistently failed to produce positive operating margins. While SG&amp;A (selling, general and administrative) expenses have fallen by roughly $5 million each of the previous three years, it hasn’t resulted in sustained positive margins. To help hide the negative operating and profit margins, management tends to focus on adjusted EBITDA. This is simply an alternate accounting method, which hides real world expenses and shouldn’t be considered a route to profitability.”\n</blockquote>\n<p>Furthermore, analyst earnings per share (EPS) estimates for 2021 and 2022 are only 3 cents and 4 cents, respectively, despite revenue estimates of about $323 and $364 million for the same period. So, although transportation issues were and are abundant during the novel coronavirus pandemic, the profitability issues don’t seem to be subsiding for Clean Energy Fuels.</p>\n<p><b>Bottom Line on CLNE Stock</b></p>\n<p>As a whole, Clean Energy stock was a Reddit meme driven favorite earlier in the year. In fact, shares are up more than 200% over the past year after hitting a high of $19.79 per share in February.</p>\n<p>However, CLNE stock has really taken a tumble in the months since — losing nearly 60% of its value. And unless the company offers a clear path to much higher margins, the stock will likely return to its long-term trading range of $2 to $3.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Clean Energy Fuels Has Plenty of Work To Do</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Clean Energy Fuels Has Plenty of Work To Do\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 13:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/08/clean-energy-fuels-clne-stock-continues-to-hunt-for-higher-margins/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Clean Energy Fuels history of low to zero margins will keep the stock down unless they turn things around\nYes, it’s possible to invest in cow poo — or at least the product that is derived from it. ...</p>\n\n<a href=\"https://investorplace.com/2021/08/clean-energy-fuels-clne-stock-continues-to-hunt-for-higher-margins/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLNE":"Clean Energy Fuels Corp"},"source_url":"https://investorplace.com/2021/08/clean-energy-fuels-clne-stock-continues-to-hunt-for-higher-margins/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177585640","content_text":"Clean Energy Fuels history of low to zero margins will keep the stock down unless they turn things around\nYes, it’s possible to invest in cow poo — or at least the product that is derived from it. Renewable natural gas (RNG) is a transportation fuel made from organic waste, primarily from cattle. Once it’s purified, this biomethane is chemically identical to the main ingredient in the fossil-based natural gas that comes out of a stove or heats residential water. The use of RNGs drastically reduces carbon emissions, and unlike conventional natural gas, RNG is not a fossil fuel and does not involve drilling. That said, the leader in this sector is Clean Energy Fuels(NASDAQ:CLNE) — but CLNE stock may lose its one-year gains of the firm doesn’t figure things out.\nOverall, Clean Energy Fuels provides natural gas as an alternative fuel for vehicle fleets and related fueling solutions, primarily in the United States and Canada. It supplies RNG, compressed natural gas (CNG) and liquefied natural gas (LNG) for light, medium, and heavy-duty vehicles. Additionally, the company offers operation and maintenance services for public and private vehicle fleet customer stations.\nMoreover, the company also designs, builds, operates and maintains fueling stations. It also sells and services compressors and other equipment that are used in fueling stations, and provides assessment, design and modification solutions to offer operators with code-compliant service and maintenance facilities for natural gas vehicle fleets.\nCollectively, Clean Energy Fuels serves heavy-duty trucking, airports, refuse, public transit, industrial, and institutional energy users, as well as government fleets. As of December 31, 2020, it served approximately 1,000 fleet customers operating approximately 48,000 vehicles. And it also owned, operated, or supplied approximately 565 fueling stations in 39 states in the United States and five provinces in Canada.\nThe Opportunity and Benefit of Clean Energy\nAccording to the company, livestock manure and landfills account for 27% of methane emissions in the U.S. That said, this is the original source of where Clean Energy Fuels gets its RNG.\nWhen organic matter decays, it naturally produces methane — one of the greenhouse gases most detrimental to the environment. So, by capturing the methane, the company prevents it from entering and damaging the atmosphere. Then, they can then turn it into clean fuel for the transportation industry. That said, the transportation industry — as a whole — was responsible for 29% of the total greenhouse gas emissions in the U.S. in 2019.\nThis all sounds great, so there must be a catch. Well, the catch is that Clean Energy Fuels has been around a very long time, but still cant generate consistent high margin profits. That said, here is a very-detailed explanation of why the company is struggling in that department:\n\n “…The only logical explanation is that Clean Energy owns a very small percentage of the 540 fueling stations spread across the USA. It operates, maintains and supplies the fueling station with natural gases at commodity prices plus charges for transportation, compression, storage and maintenance. While Clean Energy has adopted an excellent business model, unfortunately, it operates in an area of the value chain with minimal operating margins.”\n\n\n “Over the past five years, Clean Energy Fuels has consistently failed to produce positive operating margins. While SG&A (selling, general and administrative) expenses have fallen by roughly $5 million each of the previous three years, it hasn’t resulted in sustained positive margins. To help hide the negative operating and profit margins, management tends to focus on adjusted EBITDA. This is simply an alternate accounting method, which hides real world expenses and shouldn’t be considered a route to profitability.”\n\nFurthermore, analyst earnings per share (EPS) estimates for 2021 and 2022 are only 3 cents and 4 cents, respectively, despite revenue estimates of about $323 and $364 million for the same period. So, although transportation issues were and are abundant during the novel coronavirus pandemic, the profitability issues don’t seem to be subsiding for Clean Energy Fuels.\nBottom Line on CLNE Stock\nAs a whole, Clean Energy stock was a Reddit meme driven favorite earlier in the year. In fact, shares are up more than 200% over the past year after hitting a high of $19.79 per share in February.\nHowever, CLNE stock has really taken a tumble in the months since — losing nearly 60% of its value. And unless the company offers a clear path to much higher margins, the stock will likely return to its long-term trading range of $2 to $3.","news_type":1},"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804668817,"gmtCreate":1627954497639,"gmtModify":1703498470745,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Like and comment please","listText":"Like and comment please","text":"Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804668817","repostId":"2156823112","repostType":4,"isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804661501,"gmtCreate":1627954459403,"gmtModify":1703498469776,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/804661501","repostId":"1113979236","repostType":4,"isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804669061,"gmtCreate":1627954322053,"gmtModify":1703498465246,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804669061","repostId":"1133429741","repostType":4,"repost":{"id":"1133429741","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1627953054,"share":"https://ttm.financial/m/news/1133429741?lang=&edition=fundamental","pubTime":"2021-08-03 09:10","market":"us","language":"en","title":"Apple Topples Saudi Aramco To Be The Most Profitable Fortune Global 500 Company In 2020","url":"https://stock-news.laohu8.com/highlight/detail?id=1133429741","media":"Benzinga","summary":"Apple, Inc.'s all-around product momentum has taken it to the top of the charts in terms of profitab","content":"<p><b>Apple, Inc.'s</b>&nbsp;all-around product momentum has taken it to the top of the charts in terms of profitability.</p>\n<p><b>Cupertino Tops On Profits:</b>Apple, with $67 million in profits for the fiscal year 2020, was the leader in the Fortune Global 500, released today.</p>\n<p>Apple wrested the No. 1 \"Most Profitable\" ranking&nbsp;from Saudi Arabian oil giant&nbsp;<b>Saudi Aramco,</b>which held the top spot for two straight years. The company reported profits of $49.287 billion for the year.<b>SoftBank Group Corp. - ADR</b>&nbsp;took the third position with $47.053 billion in profit.</p>\n<p><b>Walmart Inc.</b>&nbsp;was the top revenue-generating global company for the eighth consecutive year. Theretail giant&nbsp;clocked revenues of $523.964 billion for the fiscal year 2020. State-owned Chinese electricity utility&nbsp;<b>State Grid</b>&nbsp;followed with $383.906 billion in revenues.</p>\n<p><b>Amazon.com, Inc.</b>&nbsp;was in third place by virtue of its $280.522 billion revenues. The fourth and fifth places were taken by integrated oil companies&nbsp;<b>China National Petroleum</b>&nbsp;and&nbsp;<b>Sinopec Shanghai Petrochemical Co</b>.</p>\n<p><b>Apple was placed sixth in terms of revenue, a jump from the 12th position it held previously.</b></p>\n<p>The Fortune 500 companies generated revenues of $31.7 trillion, down 5%, and profits of $1.6 trillion, down  20%, the report showed. The companies employ 69.7 million people worldwide.</p>\n<p>Fortune blamed the softness relative to the previous year and&nbsp;the COVID-19 pandemic.</p>\n<p><b>Apple Juggernaut Rolls On:</b>Last week,&nbsp;Apple&nbsp;reported&nbsp;record June quarter results, with both revenues and earnings surpassing expectations.</p>\n<p>\"With 5G now in the cards and roughly 40% of its 'golden jewel'&nbsp;iPhone installed base not upgrading their phones in the last 3.5 years, Cook &amp; Co. have the stage set for a renaissance of growth in Cupertino,\" Wedbush analyst Daniel Ives said in a note reviewing the company's quarterly results.</p>\n<p>At last check, Apple shares were down 0.23% at $145.52.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Topples Saudi Aramco To Be The Most Profitable Fortune Global 500 Company In 2020</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Topples Saudi Aramco To Be The Most Profitable Fortune Global 500 Company In 2020\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-03 09:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Apple, Inc.'s</b>&nbsp;all-around product momentum has taken it to the top of the charts in terms of profitability.</p>\n<p><b>Cupertino Tops On Profits:</b>Apple, with $67 million in profits for the fiscal year 2020, was the leader in the Fortune Global 500, released today.</p>\n<p>Apple wrested the No. 1 \"Most Profitable\" ranking&nbsp;from Saudi Arabian oil giant&nbsp;<b>Saudi Aramco,</b>which held the top spot for two straight years. The company reported profits of $49.287 billion for the year.<b>SoftBank Group Corp. - ADR</b>&nbsp;took the third position with $47.053 billion in profit.</p>\n<p><b>Walmart Inc.</b>&nbsp;was the top revenue-generating global company for the eighth consecutive year. Theretail giant&nbsp;clocked revenues of $523.964 billion for the fiscal year 2020. State-owned Chinese electricity utility&nbsp;<b>State Grid</b>&nbsp;followed with $383.906 billion in revenues.</p>\n<p><b>Amazon.com, Inc.</b>&nbsp;was in third place by virtue of its $280.522 billion revenues. The fourth and fifth places were taken by integrated oil companies&nbsp;<b>China National Petroleum</b>&nbsp;and&nbsp;<b>Sinopec Shanghai Petrochemical Co</b>.</p>\n<p><b>Apple was placed sixth in terms of revenue, a jump from the 12th position it held previously.</b></p>\n<p>The Fortune 500 companies generated revenues of $31.7 trillion, down 5%, and profits of $1.6 trillion, down  20%, the report showed. The companies employ 69.7 million people worldwide.</p>\n<p>Fortune blamed the softness relative to the previous year and&nbsp;the COVID-19 pandemic.</p>\n<p><b>Apple Juggernaut Rolls On:</b>Last week,&nbsp;Apple&nbsp;reported&nbsp;record June quarter results, with both revenues and earnings surpassing expectations.</p>\n<p>\"With 5G now in the cards and roughly 40% of its 'golden jewel'&nbsp;iPhone installed base not upgrading their phones in the last 3.5 years, Cook &amp; Co. have the stage set for a renaissance of growth in Cupertino,\" Wedbush analyst Daniel Ives said in a note reviewing the company's quarterly results.</p>\n<p>At last check, Apple shares were down 0.23% at $145.52.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SFTBY":"软银集团","AAPL":"苹果","AMZN":"亚马逊","WMT":"沃尔玛"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133429741","content_text":"Apple, Inc.'s all-around product momentum has taken it to the top of the charts in terms of profitability.\nCupertino Tops On Profits:Apple, with $67 million in profits for the fiscal year 2020, was the leader in the Fortune Global 500, released today.\nApple wrested the No. 1 \"Most Profitable\" ranking from Saudi Arabian oil giant Saudi Aramco,which held the top spot for two straight years. The company reported profits of $49.287 billion for the year.SoftBank Group Corp. - ADR took the third position with $47.053 billion in profit.\nWalmart Inc. was the top revenue-generating global company for the eighth consecutive year. Theretail giant clocked revenues of $523.964 billion for the fiscal year 2020. State-owned Chinese electricity utility State Grid followed with $383.906 billion in revenues.\nAmazon.com, Inc. was in third place by virtue of its $280.522 billion revenues. The fourth and fifth places were taken by integrated oil companies China National Petroleum and Sinopec Shanghai Petrochemical Co.\nApple was placed sixth in terms of revenue, a jump from the 12th position it held previously.\nThe Fortune 500 companies generated revenues of $31.7 trillion, down 5%, and profits of $1.6 trillion, down  20%, the report showed. The companies employ 69.7 million people worldwide.\nFortune blamed the softness relative to the previous year and the COVID-19 pandemic.\nApple Juggernaut Rolls On:Last week, Apple reported record June quarter results, with both revenues and earnings surpassing expectations.\n\"With 5G now in the cards and roughly 40% of its 'golden jewel' iPhone installed base not upgrading their phones in the last 3.5 years, Cook & Co. have the stage set for a renaissance of growth in Cupertino,\" Wedbush analyst Daniel Ives said in a note reviewing the company's quarterly results.\nAt last check, Apple shares were down 0.23% at $145.52.","news_type":1},"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805049439,"gmtCreate":1627828042521,"gmtModify":1703496343938,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Like and shaee","listText":"Like and shaee","text":"Like and shaee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805049439","repostId":"1122171439","repostType":4,"repost":{"id":"1122171439","kind":"news","pubTimestamp":1627786350,"share":"https://ttm.financial/m/news/1122171439?lang=&edition=fundamental","pubTime":"2021-08-01 10:52","market":"us","language":"en","title":"Alphabet Is Worth $3,554 Based on Its Powerful Free Cash Flow","url":"https://stock-news.laohu8.com/highlight/detail?id=1122171439","media":"InvestorPlace","summary":"GOOG stock will benefit in 2022 from its higher FCF margins, so that with a 3.2% FCF yield it will be worth 30% more.Alphabet just reported stellar second-quarter results, in terms of both revenue and earnings. But even more importantly, its free cash flow  grew substantially, both in absolute numbers and FCF margins. As a result, I believe that GOOG stock is now worth at least 30% more or $3,554 per share. This article will describe how I came up with that valuation.On July 27, Alphabet, the pa","content":"<blockquote>\n GOOG stock will benefit in 2022 from its higher FCF margins, so that with a 3.2% FCF yield it will be worth 30% more.\n</blockquote>\n<p><b>Alphabet</b>(NASDAQ:<b><u>GOOG</u></b>, NASDAQ:<b><u>GOOGL</u></b>) just reported stellar second-quarter results, in terms of both revenue and earnings. But even more importantly, its free cash flow (FCF) grew substantially, both in absolute numbers and FCF margins. As a result, I believe that GOOG stock is now worth at least 30% more or $3,554 per share. This article will describe how I came up with that valuation.</p>\n<p>On July 27, Alphabet, the parent of online search engine Google that makes most of its money from advertising, reported a huge 62% revenue gain on a year-0ver-year (YOY) basis. Even on a quarter-over-quarter basis, its revenue of $61.88 billion in Q2 grew by 11.87% from $55.314 billion in Q1.</p>\n<p>That implies an annualized run rate of 56.6%. So that coincides with its historical 62% YOY rate, implying that next year the company will show 57% YOY revenue growth.</p>\n<p>Of course, this assumes that advertising growth — and the economy in general — stay red hot.</p>\n<p><b>Estimating Google’s FCF</b></p>\n<p>But more importantly, its FCF rose to $16.394 billion, which can beseen on page 7of the earnings release. Alphabet is one of the few companies that help investors by calculating their own FCF figures. For example, last quarter its FCF was $13.347 billion (also onpage 7 of the Q1 report). This shows that its quarterly FCF growth was 22.83% just on a QOQ basis. That implies a huge run rate growth rate, although this is not what I will use to project out its future FCF.</p>\n<p>I think it is better to look at Alphabet’s FCF margins to forecast its future FCF. For example, in Q2 its $16.4 billion FCF represents 26.5% of its $61.88 billion in revenue. That is a huge gain over its FCF margins. Dividing $13.347 billion in Q1 FCF by revenue of $55.314 billion shows that Q1 FCF margins were just 24.1%.</p>\n<p>So, going forward let’s estimate that FCF will be 26.5% of its forecast revenue. For example,<i>Seeking Alpha</i>shows that analystsproject 2021 revenue of $250.29 billion. That implies its 2021 FCF will be $66.3 billion this year. But this is likely now already implied or discounted in the GOOG stock price.</p>\n<p>We should probably use 2022 estimates since the market will soon start valuing GOOG stock on its 2002 numbers. Seeking Alpha indicates $286.36 billion for 2022. Applying the 26.5% FCF margin to this estimate yields an FCF estimate of $75.89 billion. That is substantially higher than the estimates for 2021 FCF. We can now use this to value GOOG stock.</p>\n<p><b>What GOOG Stock Is Now Worth</b></p>\n<p>One way to value GOOG stock is to use its historical FCF yield and apply it to our future FCF estimate. For example, in the trailing 12 months (TTM) to June 30, Alphabet produced $58.536 billion in FCF. This can be seen on<i>Seeking Alpha’s</i>historical FCF pageby subtracting its TTM capex from its TTM cash flow from operations. Here is how we will use this.</p>\n<p>First, we calculate its historical TTM FCF yield. For example, the company now has a market capitalization of $1.826 trillion, according to<i>Yahoo! Finance</i>, which usually has the best calculations. Therefore, if we divide its TTM FCF of $58.536 by its $1,826 billion market cap, the FCF yield works out to 3.2%.</p>\n<p>Next, we can divide our forecast of $75.89 billion in 2022 FCF by its TTM FCF yield of 3.2%. That derives a new target market value of $2.37 trillion. In other words, GOOG stock has a target market cap that is 29.88% higher than today’s price. Therefore, using yesterday’s closing price of $2,730.81, its target price is $3,546 per share.</p>\n<p><b>What To Do With GOOG Stock</b></p>\n<p>In other words, starting with the company’s much higher FCF margins and projecting these out against 2022 revenue, GOOG stock should rise at least 30% sometime over the next year. That assumes a fairly high 3.2% FCF yield. It is very possible that the yield could rise, which would lower the target price.</p>\n<p>For example, consider this. Above, we projected that Alphabet will produce $66.3 billion in FCF this year. But that represents a higher 3.63% FCF yield on today’s $1,826 billion market cap. Applying this higher 3.63% FCF yield to its 2022 estimates would result in a lower price target than my 30% expected gain.</p>\n<p>I don’t think that is what will happen in reality. Don’t forget that we assume that the company will have a much higher FCF margin in 2022 than its historical TTM FCF. Therefore, the value of the company should be higher. That implies the FCF yield should be low such as the 3.2% FCF yield I used. If you are following me so far, this means that my projections are likely to come to pass on a historical basis, albeit in the future.</p>\n<p>Bottom line — GOOG stock is a buy, as it is likely to move at least 30% higher assuming its FCF stays as strong as just shown in Q2.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alphabet Is Worth $3,554 Based on Its Powerful Free Cash Flow</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlphabet Is Worth $3,554 Based on Its Powerful Free Cash Flow\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 10:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/goog-stock-is-worth-3554-or-30-percent-more-based-on-26-5-percent-fcf-margins/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GOOG stock will benefit in 2022 from its higher FCF margins, so that with a 3.2% FCF yield it will be worth 30% more.\n\nAlphabet(NASDAQ:GOOG, NASDAQ:GOOGL) just reported stellar second-quarter results,...</p>\n\n<a href=\"https://investorplace.com/2021/07/goog-stock-is-worth-3554-or-30-percent-more-based-on-26-5-percent-fcf-margins/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09086":"华夏纳指-U","QNETCN":"纳斯达克中美互联网老虎指数","GOOGL":"谷歌A","03086":"华夏纳指","GOOG":"谷歌"},"source_url":"https://investorplace.com/2021/07/goog-stock-is-worth-3554-or-30-percent-more-based-on-26-5-percent-fcf-margins/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122171439","content_text":"GOOG stock will benefit in 2022 from its higher FCF margins, so that with a 3.2% FCF yield it will be worth 30% more.\n\nAlphabet(NASDAQ:GOOG, NASDAQ:GOOGL) just reported stellar second-quarter results, in terms of both revenue and earnings. But even more importantly, its free cash flow (FCF) grew substantially, both in absolute numbers and FCF margins. As a result, I believe that GOOG stock is now worth at least 30% more or $3,554 per share. This article will describe how I came up with that valuation.\nOn July 27, Alphabet, the parent of online search engine Google that makes most of its money from advertising, reported a huge 62% revenue gain on a year-0ver-year (YOY) basis. Even on a quarter-over-quarter basis, its revenue of $61.88 billion in Q2 grew by 11.87% from $55.314 billion in Q1.\nThat implies an annualized run rate of 56.6%. So that coincides with its historical 62% YOY rate, implying that next year the company will show 57% YOY revenue growth.\nOf course, this assumes that advertising growth — and the economy in general — stay red hot.\nEstimating Google’s FCF\nBut more importantly, its FCF rose to $16.394 billion, which can beseen on page 7of the earnings release. Alphabet is one of the few companies that help investors by calculating their own FCF figures. For example, last quarter its FCF was $13.347 billion (also onpage 7 of the Q1 report). This shows that its quarterly FCF growth was 22.83% just on a QOQ basis. That implies a huge run rate growth rate, although this is not what I will use to project out its future FCF.\nI think it is better to look at Alphabet’s FCF margins to forecast its future FCF. For example, in Q2 its $16.4 billion FCF represents 26.5% of its $61.88 billion in revenue. That is a huge gain over its FCF margins. Dividing $13.347 billion in Q1 FCF by revenue of $55.314 billion shows that Q1 FCF margins were just 24.1%.\nSo, going forward let’s estimate that FCF will be 26.5% of its forecast revenue. For example,Seeking Alphashows that analystsproject 2021 revenue of $250.29 billion. That implies its 2021 FCF will be $66.3 billion this year. But this is likely now already implied or discounted in the GOOG stock price.\nWe should probably use 2022 estimates since the market will soon start valuing GOOG stock on its 2002 numbers. Seeking Alpha indicates $286.36 billion for 2022. Applying the 26.5% FCF margin to this estimate yields an FCF estimate of $75.89 billion. That is substantially higher than the estimates for 2021 FCF. We can now use this to value GOOG stock.\nWhat GOOG Stock Is Now Worth\nOne way to value GOOG stock is to use its historical FCF yield and apply it to our future FCF estimate. For example, in the trailing 12 months (TTM) to June 30, Alphabet produced $58.536 billion in FCF. This can be seen onSeeking Alpha’shistorical FCF pageby subtracting its TTM capex from its TTM cash flow from operations. Here is how we will use this.\nFirst, we calculate its historical TTM FCF yield. For example, the company now has a market capitalization of $1.826 trillion, according toYahoo! Finance, which usually has the best calculations. Therefore, if we divide its TTM FCF of $58.536 by its $1,826 billion market cap, the FCF yield works out to 3.2%.\nNext, we can divide our forecast of $75.89 billion in 2022 FCF by its TTM FCF yield of 3.2%. That derives a new target market value of $2.37 trillion. In other words, GOOG stock has a target market cap that is 29.88% higher than today’s price. Therefore, using yesterday’s closing price of $2,730.81, its target price is $3,546 per share.\nWhat To Do With GOOG Stock\nIn other words, starting with the company’s much higher FCF margins and projecting these out against 2022 revenue, GOOG stock should rise at least 30% sometime over the next year. That assumes a fairly high 3.2% FCF yield. It is very possible that the yield could rise, which would lower the target price.\nFor example, consider this. Above, we projected that Alphabet will produce $66.3 billion in FCF this year. But that represents a higher 3.63% FCF yield on today’s $1,826 billion market cap. Applying this higher 3.63% FCF yield to its 2022 estimates would result in a lower price target than my 30% expected gain.\nI don’t think that is what will happen in reality. Don’t forget that we assume that the company will have a much higher FCF margin in 2022 than its historical TTM FCF. Therefore, the value of the company should be higher. That implies the FCF yield should be low such as the 3.2% FCF yield I used. If you are following me so far, this means that my projections are likely to come to pass on a historical basis, albeit in the future.\nBottom line — GOOG stock is a buy, as it is likely to move at least 30% higher assuming its FCF stays as strong as just shown in Q2.","news_type":1},"isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805040601,"gmtCreate":1627827848603,"gmtModify":1703496341798,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805040601","repostId":"2155001152","repostType":4,"repost":{"id":"2155001152","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627675228,"share":"https://ttm.financial/m/news/2155001152?lang=&edition=fundamental","pubTime":"2021-07-31 04:00","market":"us","language":"en","title":"Wall Street declines with Amazon; S&P 500 posts gains for month","url":"https://stock-news.laohu8.com/highlight/detail?id=2155001152","media":"Reuters","summary":"U.S. consumer spending rises in June, inflation increases . NEW YORK, July 30  - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&P 500 still posted a sixth straight month of gains.Amazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.Shares of oth","content":"<ul>\n <li>Pinterest sinks on stalled U.S. user growth</li>\n <li>U.S. consumer spending rises in June, inflation increases (Updates to close)</li>\n</ul>\n<p>NEW YORK, July 30 (Reuters) - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&amp;P 500 still posted a sixth straight month of gains.</p>\n<p>Amazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.</p>\n<p>Shares of other internet and tech giants that did well during the lockdowns of last year, including Google parent Alphabet Inc and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc, were mostly lower.</p>\n<p>\"Overall earnings have been good. But Amazon ... and some of last year's winners are taking some of the air out of the market today,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"This market has been driven by big tech and when tech does well, the market seems to go right along with it, and when it doesn't,\" it falls.</p>\n<p>Data on Friday showed U.S. consumer spending rose more than expected in June, although annual inflation accelerated further above the Federal Reserve's 2% target.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 146.36 points, or 0.42%, to 34,938.17, the S&amp;P 500 lost 23.58 points, or 0.53%, to 4,395.57 and the Nasdaq Composite dropped 101.51 points, or 0.69%, to 14,676.76.</p>\n<p>Strong earnings and the continued rebound in the U.S. economy have helped to support stocks this month, but the rapid spread of the Delta variant of the coronavirus and rising inflation have been concerns.</p>\n<p>\"There are still some distant jitters, whispers about the Delta variant, about cases rising, and I think some underlying worries about a slowdown of the reopenings and possible reversal,\" Dollarhide said.</p>\n<p>Also on the earnings front, Pampers maker Procter &amp; Gamble Co rose as it forecast higher core earnings for this year, and U.S.-listed shares of Canada's <a href=\"https://laohu8.com/S/QSR\">Restaurant Brands International Inc</a> jumped after the Burger King owner beat estimates for quarterly profit.</p>\n<p>Pinterest Inc, however, plunged after saying U.S. user growth was decelerating as people who used the platform for crafts and DIY projects during the height of the pandemic were stepping out more.</p>\n<p>Caterpillar Inc shares also fell, even though the company posted a rise in second-quarter adjusted profit on the back of a recovery in global economic activity.</p>\n<p>Results on the quarter overall have been much stronger than expected, with about 89% of the reports beating analysts' estimates on earnings, according to IBES data from Refinitiv. Earnings are now expected to have climbed 89.8% in the second quarter versus forecasts of 65.4% at the start of July. (Reporting by Caroline Valetkevitch in New York Additional reporting by Sagarika Jaisinghani in Bengaluru Editing by Arun Koyyur and Matthew Lewis)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street declines with Amazon; S&P 500 posts gains for month</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street declines with Amazon; S&P 500 posts gains for month\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-31 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Pinterest sinks on stalled U.S. user growth</li>\n <li>U.S. consumer spending rises in June, inflation increases (Updates to close)</li>\n</ul>\n<p>NEW YORK, July 30 (Reuters) - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&amp;P 500 still posted a sixth straight month of gains.</p>\n<p>Amazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.</p>\n<p>Shares of other internet and tech giants that did well during the lockdowns of last year, including Google parent Alphabet Inc and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc, were mostly lower.</p>\n<p>\"Overall earnings have been good. But Amazon ... and some of last year's winners are taking some of the air out of the market today,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"This market has been driven by big tech and when tech does well, the market seems to go right along with it, and when it doesn't,\" it falls.</p>\n<p>Data on Friday showed U.S. consumer spending rose more than expected in June, although annual inflation accelerated further above the Federal Reserve's 2% target.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 146.36 points, or 0.42%, to 34,938.17, the S&amp;P 500 lost 23.58 points, or 0.53%, to 4,395.57 and the Nasdaq Composite dropped 101.51 points, or 0.69%, to 14,676.76.</p>\n<p>Strong earnings and the continued rebound in the U.S. economy have helped to support stocks this month, but the rapid spread of the Delta variant of the coronavirus and rising inflation have been concerns.</p>\n<p>\"There are still some distant jitters, whispers about the Delta variant, about cases rising, and I think some underlying worries about a slowdown of the reopenings and possible reversal,\" Dollarhide said.</p>\n<p>Also on the earnings front, Pampers maker Procter &amp; Gamble Co rose as it forecast higher core earnings for this year, and U.S.-listed shares of Canada's <a href=\"https://laohu8.com/S/QSR\">Restaurant Brands International Inc</a> jumped after the Burger King owner beat estimates for quarterly profit.</p>\n<p>Pinterest Inc, however, plunged after saying U.S. user growth was decelerating as people who used the platform for crafts and DIY projects during the height of the pandemic were stepping out more.</p>\n<p>Caterpillar Inc shares also fell, even though the company posted a rise in second-quarter adjusted profit on the back of a recovery in global economic activity.</p>\n<p>Results on the quarter overall have been much stronger than expected, with about 89% of the reports beating analysts' estimates on earnings, according to IBES data from Refinitiv. Earnings are now expected to have climbed 89.8% in the second quarter versus forecasts of 65.4% at the start of July. (Reporting by Caroline Valetkevitch in New York Additional reporting by Sagarika Jaisinghani in Bengaluru Editing by Arun Koyyur and Matthew Lewis)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SSO":"两倍做多标普500ETF","OEX":"标普100","COMP":"Compass, Inc.","AMZN":"亚马逊","CAT":"卡特彼勒","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF",".SPX":"S&P 500 Index","UPRO":"三倍做多标普500ETF","OEF":"标普100指数ETF-iShares","SDS":"两倍做空标普500ETF","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155001152","content_text":"Pinterest sinks on stalled U.S. user growth\nU.S. consumer spending rises in June, inflation increases (Updates to close)\n\nNEW YORK, July 30 (Reuters) - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&P 500 still posted a sixth straight month of gains.\nAmazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.\nShares of other internet and tech giants that did well during the lockdowns of last year, including Google parent Alphabet Inc and Facebook Inc, were mostly lower.\n\"Overall earnings have been good. But Amazon ... and some of last year's winners are taking some of the air out of the market today,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"This market has been driven by big tech and when tech does well, the market seems to go right along with it, and when it doesn't,\" it falls.\nData on Friday showed U.S. consumer spending rose more than expected in June, although annual inflation accelerated further above the Federal Reserve's 2% target.\nUnofficially, the Dow Jones Industrial Average fell 146.36 points, or 0.42%, to 34,938.17, the S&P 500 lost 23.58 points, or 0.53%, to 4,395.57 and the Nasdaq Composite dropped 101.51 points, or 0.69%, to 14,676.76.\nStrong earnings and the continued rebound in the U.S. economy have helped to support stocks this month, but the rapid spread of the Delta variant of the coronavirus and rising inflation have been concerns.\n\"There are still some distant jitters, whispers about the Delta variant, about cases rising, and I think some underlying worries about a slowdown of the reopenings and possible reversal,\" Dollarhide said.\nAlso on the earnings front, Pampers maker Procter & Gamble Co rose as it forecast higher core earnings for this year, and U.S.-listed shares of Canada's Restaurant Brands International Inc jumped after the Burger King owner beat estimates for quarterly profit.\nPinterest Inc, however, plunged after saying U.S. user growth was decelerating as people who used the platform for crafts and DIY projects during the height of the pandemic were stepping out more.\nCaterpillar Inc shares also fell, even though the company posted a rise in second-quarter adjusted profit on the back of a recovery in global economic activity.\nResults on the quarter overall have been much stronger than expected, with about 89% of the reports beating analysts' estimates on earnings, according to IBES data from Refinitiv. Earnings are now expected to have climbed 89.8% in the second quarter versus forecasts of 65.4% at the start of July. (Reporting by Caroline Valetkevitch in New York Additional reporting by Sagarika Jaisinghani in Bengaluru Editing by Arun Koyyur and Matthew Lewis)","news_type":1},"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109921064,"gmtCreate":1619659987858,"gmtModify":1704727543798,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581829779229670","idStr":"3581829779229670"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109921064","repostId":"1137964402","repostType":4,"repost":{"id":"1137964402","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619651546,"share":"https://ttm.financial/m/news/1137964402?lang=&edition=fundamental","pubTime":"2021-04-29 07:12","market":"us","language":"en","title":"Apple reports another blowout quarter with sales up 54%, authorizes $90 billion in share buybacks","url":"https://stock-news.laohu8.com/highlight/detail?id=1137964402","media":"Tiger Newspress","summary":"Apple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and significantly stronger profits than Wall Street expected.Apple did not issue official guidance for what it expects in the quarter ending in June.Apple authorized $90 billion in share buybacks.Apple stock rose over 4% at one point in extended trading.Apple reported double-digit growth in every single one of its product categories, and its most important product line, the iPhone, was up 65","content":"<p><b>KEY POINTS</b></p><ul><li>Apple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and&nbsp;significantly stronger profits than Wall Street expected.</li><li>Apple did not issue official guidance for what it expects in the quarter ending in June.</li><li>Apple authorized $90 billion in share buybacks.</li></ul><p>Apple&nbsp;reported&nbsp;a blowout quarter&nbsp;on Wednesday, announcing companywide sales up 54% higher than last year, and&nbsp;significantly stronger profits than Wall Street expected.</p><p>Apple stock rose over 4% at one point in extended trading.</p><p><img src=\"https://static.tigerbbs.com/4e791f63f460807906f1793c2d58933e\" tg-width=\"1302\" tg-height=\"833\"></p><p>Apple reported double-digit growth in every single one of its product categories, and its&nbsp;most important product line, the iPhone, was up 65.5% from last year. Its Mac and iPad sales&nbsp;did&nbsp;better, with its computers up 70.1% and iPad&nbsp;sales&nbsp;growing nearly 79% on an annual basis.</p><p>Apple said it would increase its dividend by 7%&nbsp;to $0.22 per share&nbsp;and authorized $90 billion in share buybacks, which is significantly higher than last year’s $50 billion outlay&nbsp;and 2019′s $75 billion.</p><p>Here’s how Apple did versus Refinitiv estimates:</p><ul><li><b>EPS</b>:&nbsp;$1.40&nbsp;vs. $0.99 estimated</li><li><b>Revenue</b>:&nbsp;$89.58&nbsp;billion&nbsp;vs. $77.36&nbsp;billion&nbsp;estimated, up 53.7% year-over-year</li><li><b>iPhone revenue</b>:&nbsp;$47.94 billion&nbsp;vs. $41.43&nbsp;billion&nbsp;estimated, up&nbsp;65.5% year-over-year</li><li><b>Services revenue</b>:&nbsp;$16.90 billion&nbsp;vs. $15.57&nbsp;billion&nbsp;estimated, up 26.7% year over&nbsp;year</li><li><b>Other Products revenue</b>:&nbsp;$7.83&nbsp;billion&nbsp;vs. $7.79&nbsp;billion&nbsp;estimated,&nbsp;up 24%&nbsp;year-over-year</li><li><b>Mac revenue</b>:&nbsp;$9.10&nbsp;billion&nbsp;vs. $6.86&nbsp;billion&nbsp;estimated, up 70.1% year-over-year</li><li><b>iPad revenue</b>:&nbsp;$7.80 billion&nbsp;vs. $5.58&nbsp;billion&nbsp;estimated, up 78.9% year-over-year</li><li><b>Gross margin</b>:&nbsp;42.5% vs. 39.8%&nbsp;estimated</li></ul><p>Apple did not issue official guidance for what it expects in the quarter ending in June. It hasn’t provided revenue&nbsp;guidance since the start of the pandemic, citing uncertainty.&nbsp;This is Apple’s second quarter in a row with double-digit growth in all product categories.&nbsp;Apple CFO Luca Maestri told analysts that the company expects June quarter revenue to rise by double digits year-over-year, although it faces some supply shortages due to the worldwide chip shortage.</p><p>Apple has said in the past months that its business has been boosted by the pandemic as consumers&nbsp;and businesses&nbsp;bought&nbsp;computers&nbsp;to work and entertain themselves while at home. But Apple’s strong results in the quarter suggest that the trend may persist as more economies&nbsp;open up.</p><p>Or, as Apple CEO Tim Cook said in a statement: “This quarter reflects both the enduring ways our products have helped our users meet this&nbsp;moment in their own lives, as well as the optimism consumers seem to feel about better days&nbsp;ahead for all of us.”</p><p>Mac sales were up 70%, and Cook said that the result was “fueled by” the company’s introduction of its Mac&nbsp;laptops&nbsp;that used its own M1 chips&nbsp;for longer battery life, instead of processors sold by&nbsp;Intel.&nbsp;iPad sales were up&nbsp;nearly 79% year-over-year.</p><p>Neither of those&nbsp;results&nbsp;include iPad Pro or iMac models the company announced in March, which are expected to drive additional demand.</p><p>“We’re seeing strong first-time buyers on the Mac&nbsp;…&nbsp;it continues to run just south of 50%,” Cook told CNBC’s Josh Lipton. “And, in China, it’s even higher than that&nbsp;…&nbsp;it’s more around two-thirds. And that speaks to people preferring to work on the Mac.”</p><p>Apple’s iPhone also reported strong results this quarter, quelling fears that the current annual cycle could slow down. Last year, Apple released iPhones with a new exterior design and 5G support, which many investors believed could prompt a major upgrade cycle, which this quarter’s results indicate.</p><p>In greater China, which includes the mainland, Hong Kong, and Taiwan,&nbsp;Apple’s revenue increased over&nbsp;87% year-over-year to $17.73 billion, although the comparison is to a quarter last year in which China was largely shut down in the early days of the pandemic.&nbsp;Every other geographical category, including the Americas and Europe, were also up on an annual basis.</p><p><img src=\"https://static.tigerbbs.com/37a8b45c92174e3c9ab224d9a85f5e2d\" tg-width=\"1910\" tg-height=\"1114\" referrerpolicy=\"no-referrer\"></p><p>Apple’s&nbsp;high-margin&nbsp;services business, including iCloud, App Store, and subscriptions like Apple Music, also showed 26.7% growth.</p><p>One metric that Apple uses to show the growth in services is the number of subscriptions it has, which not only include its own subscriptions like Apple One, but also subscriptions through its App Store.</p><p>“We now have over 660 million paid subscriptions across the services on the platform, and that’s up 40 million from the previous quarter, which is an acceleration from 35 million,” Cook told CNBC.</p><p>However, Apple’s App Store has been challenged by lawmakers and companies that say it costs too much and has too much power. A closely-watched trial with Fortnite maker Epic Games over App Store policies kicks off next week.</p><p>“The App Store has been an economic miracle. Last year, the estimates are that there was over a half a trillion dollars of economic activity because of the store. And, so, this has been just an economic gamechanger for not only the United States, but several countries around the world. And, we’re going to go in and tell our story. And we’ll see where it goes. But, we’re confident,” Cook told CNBC.</p><p>Apple’s gross margin was also unusually elevated for the company. Most quarters, it tends to be in the 38% to 39% range, but in the quarter ending in March, Apple reported 42.5% margins.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple reports another blowout quarter with sales up 54%, authorizes $90 billion in share buybacks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple reports another blowout quarter with sales up 54%, authorizes $90 billion in share buybacks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-29 07:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>KEY POINTS</b></p><ul><li>Apple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and&nbsp;significantly stronger profits than Wall Street expected.</li><li>Apple did not issue official guidance for what it expects in the quarter ending in June.</li><li>Apple authorized $90 billion in share buybacks.</li></ul><p>Apple&nbsp;reported&nbsp;a blowout quarter&nbsp;on Wednesday, announcing companywide sales up 54% higher than last year, and&nbsp;significantly stronger profits than Wall Street expected.</p><p>Apple stock rose over 4% at one point in extended trading.</p><p><img src=\"https://static.tigerbbs.com/4e791f63f460807906f1793c2d58933e\" tg-width=\"1302\" tg-height=\"833\"></p><p>Apple reported double-digit growth in every single one of its product categories, and its&nbsp;most important product line, the iPhone, was up 65.5% from last year. Its Mac and iPad sales&nbsp;did&nbsp;better, with its computers up 70.1% and iPad&nbsp;sales&nbsp;growing nearly 79% on an annual basis.</p><p>Apple said it would increase its dividend by 7%&nbsp;to $0.22 per share&nbsp;and authorized $90 billion in share buybacks, which is significantly higher than last year’s $50 billion outlay&nbsp;and 2019′s $75 billion.</p><p>Here’s how Apple did versus Refinitiv estimates:</p><ul><li><b>EPS</b>:&nbsp;$1.40&nbsp;vs. $0.99 estimated</li><li><b>Revenue</b>:&nbsp;$89.58&nbsp;billion&nbsp;vs. $77.36&nbsp;billion&nbsp;estimated, up 53.7% year-over-year</li><li><b>iPhone revenue</b>:&nbsp;$47.94 billion&nbsp;vs. $41.43&nbsp;billion&nbsp;estimated, up&nbsp;65.5% year-over-year</li><li><b>Services revenue</b>:&nbsp;$16.90 billion&nbsp;vs. $15.57&nbsp;billion&nbsp;estimated, up 26.7% year over&nbsp;year</li><li><b>Other Products revenue</b>:&nbsp;$7.83&nbsp;billion&nbsp;vs. $7.79&nbsp;billion&nbsp;estimated,&nbsp;up 24%&nbsp;year-over-year</li><li><b>Mac revenue</b>:&nbsp;$9.10&nbsp;billion&nbsp;vs. $6.86&nbsp;billion&nbsp;estimated, up 70.1% year-over-year</li><li><b>iPad revenue</b>:&nbsp;$7.80 billion&nbsp;vs. $5.58&nbsp;billion&nbsp;estimated, up 78.9% year-over-year</li><li><b>Gross margin</b>:&nbsp;42.5% vs. 39.8%&nbsp;estimated</li></ul><p>Apple did not issue official guidance for what it expects in the quarter ending in June. It hasn’t provided revenue&nbsp;guidance since the start of the pandemic, citing uncertainty.&nbsp;This is Apple’s second quarter in a row with double-digit growth in all product categories.&nbsp;Apple CFO Luca Maestri told analysts that the company expects June quarter revenue to rise by double digits year-over-year, although it faces some supply shortages due to the worldwide chip shortage.</p><p>Apple has said in the past months that its business has been boosted by the pandemic as consumers&nbsp;and businesses&nbsp;bought&nbsp;computers&nbsp;to work and entertain themselves while at home. But Apple’s strong results in the quarter suggest that the trend may persist as more economies&nbsp;open up.</p><p>Or, as Apple CEO Tim Cook said in a statement: “This quarter reflects both the enduring ways our products have helped our users meet this&nbsp;moment in their own lives, as well as the optimism consumers seem to feel about better days&nbsp;ahead for all of us.”</p><p>Mac sales were up 70%, and Cook said that the result was “fueled by” the company’s introduction of its Mac&nbsp;laptops&nbsp;that used its own M1 chips&nbsp;for longer battery life, instead of processors sold by&nbsp;Intel.&nbsp;iPad sales were up&nbsp;nearly 79% year-over-year.</p><p>Neither of those&nbsp;results&nbsp;include iPad Pro or iMac models the company announced in March, which are expected to drive additional demand.</p><p>“We’re seeing strong first-time buyers on the Mac&nbsp;…&nbsp;it continues to run just south of 50%,” Cook told CNBC’s Josh Lipton. “And, in China, it’s even higher than that&nbsp;…&nbsp;it’s more around two-thirds. And that speaks to people preferring to work on the Mac.”</p><p>Apple’s iPhone also reported strong results this quarter, quelling fears that the current annual cycle could slow down. Last year, Apple released iPhones with a new exterior design and 5G support, which many investors believed could prompt a major upgrade cycle, which this quarter’s results indicate.</p><p>In greater China, which includes the mainland, Hong Kong, and Taiwan,&nbsp;Apple’s revenue increased over&nbsp;87% year-over-year to $17.73 billion, although the comparison is to a quarter last year in which China was largely shut down in the early days of the pandemic.&nbsp;Every other geographical category, including the Americas and Europe, were also up on an annual basis.</p><p><img src=\"https://static.tigerbbs.com/37a8b45c92174e3c9ab224d9a85f5e2d\" tg-width=\"1910\" tg-height=\"1114\" referrerpolicy=\"no-referrer\"></p><p>Apple’s&nbsp;high-margin&nbsp;services business, including iCloud, App Store, and subscriptions like Apple Music, also showed 26.7% growth.</p><p>One metric that Apple uses to show the growth in services is the number of subscriptions it has, which not only include its own subscriptions like Apple One, but also subscriptions through its App Store.</p><p>“We now have over 660 million paid subscriptions across the services on the platform, and that’s up 40 million from the previous quarter, which is an acceleration from 35 million,” Cook told CNBC.</p><p>However, Apple’s App Store has been challenged by lawmakers and companies that say it costs too much and has too much power. A closely-watched trial with Fortnite maker Epic Games over App Store policies kicks off next week.</p><p>“The App Store has been an economic miracle. Last year, the estimates are that there was over a half a trillion dollars of economic activity because of the store. And, so, this has been just an economic gamechanger for not only the United States, but several countries around the world. And, we’re going to go in and tell our story. And we’ll see where it goes. But, we’re confident,” Cook told CNBC.</p><p>Apple’s gross margin was also unusually elevated for the company. Most quarters, it tends to be in the 38% to 39% range, but in the quarter ending in March, Apple reported 42.5% margins.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137964402","content_text":"KEY POINTSApple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and significantly stronger profits than Wall Street expected.Apple did not issue official guidance for what it expects in the quarter ending in June.Apple authorized $90 billion in share buybacks.Apple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and significantly stronger profits than Wall Street expected.Apple stock rose over 4% at one point in extended trading.Apple reported double-digit growth in every single one of its product categories, and its most important product line, the iPhone, was up 65.5% from last year. Its Mac and iPad sales did better, with its computers up 70.1% and iPad sales growing nearly 79% on an annual basis.Apple said it would increase its dividend by 7% to $0.22 per share and authorized $90 billion in share buybacks, which is significantly higher than last year’s $50 billion outlay and 2019′s $75 billion.Here’s how Apple did versus Refinitiv estimates:EPS: $1.40 vs. $0.99 estimatedRevenue: $89.58 billion vs. $77.36 billion estimated, up 53.7% year-over-yeariPhone revenue: $47.94 billion vs. $41.43 billion estimated, up 65.5% year-over-yearServices revenue: $16.90 billion vs. $15.57 billion estimated, up 26.7% year over yearOther Products revenue: $7.83 billion vs. $7.79 billion estimated, up 24% year-over-yearMac revenue: $9.10 billion vs. $6.86 billion estimated, up 70.1% year-over-yeariPad revenue: $7.80 billion vs. $5.58 billion estimated, up 78.9% year-over-yearGross margin: 42.5% vs. 39.8% estimatedApple did not issue official guidance for what it expects in the quarter ending in June. It hasn’t provided revenue guidance since the start of the pandemic, citing uncertainty. This is Apple’s second quarter in a row with double-digit growth in all product categories. Apple CFO Luca Maestri told analysts that the company expects June quarter revenue to rise by double digits year-over-year, although it faces some supply shortages due to the worldwide chip shortage.Apple has said in the past months that its business has been boosted by the pandemic as consumers and businesses bought computers to work and entertain themselves while at home. But Apple’s strong results in the quarter suggest that the trend may persist as more economies open up.Or, as Apple CEO Tim Cook said in a statement: “This quarter reflects both the enduring ways our products have helped our users meet this moment in their own lives, as well as the optimism consumers seem to feel about better days ahead for all of us.”Mac sales were up 70%, and Cook said that the result was “fueled by” the company’s introduction of its Mac laptops that used its own M1 chips for longer battery life, instead of processors sold by Intel. iPad sales were up nearly 79% year-over-year.Neither of those results include iPad Pro or iMac models the company announced in March, which are expected to drive additional demand.“We’re seeing strong first-time buyers on the Mac … it continues to run just south of 50%,” Cook told CNBC’s Josh Lipton. “And, in China, it’s even higher than that … it’s more around two-thirds. And that speaks to people preferring to work on the Mac.”Apple’s iPhone also reported strong results this quarter, quelling fears that the current annual cycle could slow down. Last year, Apple released iPhones with a new exterior design and 5G support, which many investors believed could prompt a major upgrade cycle, which this quarter’s results indicate.In greater China, which includes the mainland, Hong Kong, and Taiwan, Apple’s revenue increased over 87% year-over-year to $17.73 billion, although the comparison is to a quarter last year in which China was largely shut down in the early days of the pandemic. Every other geographical category, including the Americas and Europe, were also up on an annual basis.Apple’s high-margin services business, including iCloud, App Store, and subscriptions like Apple Music, also showed 26.7% growth.One metric that Apple uses to show the growth in services is the number of subscriptions it has, which not only include its own subscriptions like Apple One, but also subscriptions through its App Store.“We now have over 660 million paid subscriptions across the services on the platform, and that’s up 40 million from the previous quarter, which is an acceleration from 35 million,” Cook told CNBC.However, Apple’s App Store has been challenged by lawmakers and companies that say it costs too much and has too much power. A closely-watched trial with Fortnite maker Epic Games over App Store policies kicks off next week.“The App Store has been an economic miracle. Last year, the estimates are that there was over a half a trillion dollars of economic activity because of the store. And, so, this has been just an economic gamechanger for not only the United States, but several countries around the world. And, we’re going to go in and tell our story. And we’ll see where it goes. But, we’re confident,” Cook told CNBC.Apple’s gross margin was also unusually elevated for the company. Most quarters, it tends to be in the 38% to 39% range, but in the quarter ending in March, Apple reported 42.5% margins.","news_type":1},"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":898008164,"gmtCreate":1628438304358,"gmtModify":1703506242495,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"This is a great stock to own","listText":"This is a great stock to own","text":"This is a great stock to own","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/898008164","repostId":"1139912651","repostType":4,"isVote":1,"tweetType":1,"viewCount":423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893269942,"gmtCreate":1628265017386,"gmtModify":1703504323424,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Commented on this&nbsp;","listText":"Commented on this&nbsp;","text":"Commented on this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/893269942","repostId":"1159359820","repostType":4,"repost":{"id":"1159359820","kind":"news","pubTimestamp":1628264299,"share":"https://ttm.financial/m/news/1159359820?lang=&edition=fundamental","pubTime":"2021-08-06 23:38","market":"us","language":"en","title":"Space Race, Nasdaq, IBM, Nvidia: What to Watch When the Stock Market Opens","url":"https://stock-news.laohu8.com/highlight/detail?id=1159359820","media":"The Wall Street Journal","summary":"Stock futures are higher after Monday’s slide on Wall Street.\n\n\nTo the moon! Well, not quite, butint","content":"<blockquote>\n <b>Stock futures are higher after Monday’s slide on Wall Street.</b>\n</blockquote>\n<p></p>\n<p>To the moon! Well, not quite, butinto space at leasttoday forJeff Bezos,the billionaire baron of ecommerce. Also not going to the moon isAmazonAMZN-1.19%stock, though it is 0.3% up premarket on Tuesday morning.</p>\n<ul>\n <li>One reason for Mr. Bezos’s rocket ride is the more earthly goal of winning government contracts for the kind of less thrilling scientific projects the provide reliable revenue. His Blue Origin company is playing catch-up withElon Musk’s SpaceX.</li>\n <li>Mr. Musk’s electric vehicle makerTesla,TSLA-1.55%is getting a bit of a boost Tuesday morning ahead of the open, rising 1% premarket. It is also gaining more attention on the message boards among day traders, according to Topstonks.com. The company reports earnings next Monday and tends to see its stock rise in the days ahead as investors start hoping for exciting announcements.</li>\n <li>In the wider markets, U.S. stock futures are trending higher ahead of the open following Monday’s broad selloff. S&amp;P 500 futures and Dow futures are up 0.3%, and Nasdaq-100 futures are up 0.4%.</li>\n <li>Nasdaq the company, not the index, is itself rising premarket, up 1%, after TheWall Street Journal’s exclusivethat it will spin out its Private Market for shares in start-ups that trade among some investors before an initial public offering. The business will go into a standalone joint venture company and get investment from three Wall Street banks and SVB Financial Group, a tech specialist bank.</li>\n <li>NvidiaNVDA-1.30%is down 0.8% on large volumes following a &nbsp;3.4% rise Monday. The shares are up nearly 80% over the past year, putting the chip makerinto the top 10list of U.S. public companies. It also executed its four-for-one stock split overnight, which has given some investorsmore ways to trade the stock-performance.</li>\n <li>International Business MachinesIBM+0.54%is up 2.8% ahead of the open on Tuesday after turning in decent second-quarter numbers Monday after the close. The computing group’s efforts to refocus on cloud-based computing and spin off its old-fashioned IT services business is winning fans among investors. At the same time, it has benefitted from companies beginning to invest again as the economy reopens.</li>\n</ul>\n<ul>\n <li>Advanced Micro DevicesAMD+1.43%is rising up the chat charts on social media platforms, according to Topstonks.com, gaining popularity among retail traders. Its shares are up 0.4% premarket on good volumes following a 0.8% rise Monday.</li>\n <li>Growing chatter and chunky volumes Tuesday morning for another perennial retail favourite:AMC Entertainment.AMC-3.16%The cinema chain’s shares have taken a bit of a beating so far this month, but they are 1.7% higher premarket Tuesday.</li>\n <li>Zoom Video CommunicationsZM-3.50%is bouncing slightly Tuesday morning, up 0.4% in premarket trading after a 2.2% drop on Monday when it revealed it would buy customer service software firmFive9.FIVN-3.04%The target’s shares jumped nearly 6% Monday, are down 0.3% premarket.</li>\n <li>Shares in big U.S. investments banks, which all took a knock Monday with the drop in financial markets, look set to rebound a bit Tuesday:Goldman SachsGS+2.91%andJPMorgan ChaseJPM+2.66%are both up about 0.3%, while andMorgan StanleyMS+1.64%up about 0.5% in premarket trading.</li>\n <li>Bitcoin dropped below $30,000 Tuesday for the first time in a month.</li>\n <li>Netflix,NFLX-0.33%United AirlinesUAL-0.71%andChipotle Mexican GrillCMG-0.63%are due to report earnings after Tuesday’s close.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/6454f89ce9900ecbca7664b0da4ff6fa\" tg-width=\"761\" tg-height=\"567\" width=\"100%\" height=\"auto\"></p>\n<ul>\n <li>Stocks, commodities and other financial marketstook a stumbleMonday on growing concerns about the strength of the post-Covid-19 global recovery.</li>\n</ul>\n<p><b>Corrections &amp; Amplifications</b></p>\n<p>Nvidia shares rose 3.4% on Monday,&nbsp;July 19. An earlier version of this article incorrectly&nbsp;said that they rose 15%. A separate version of the article incorrectly said they rose 3%. (Corrected on Aug. 6)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Space Race, Nasdaq, IBM, Nvidia: What to Watch When the Stock Market Opens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSpace Race, Nasdaq, IBM, Nvidia: What to Watch When the Stock Market Opens\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-06 23:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/space-race-nvidia-and-ibm-what-to-watch-when-the-market-opens-11626778707?mod=rss_markets_main><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock futures are higher after Monday’s slide on Wall Street.\n\n\nTo the moon! Well, not quite, butinto space at leasttoday forJeff Bezos,the billionaire baron of ecommerce. Also not going to the moon ...</p>\n\n<a href=\"https://www.wsj.com/articles/space-race-nvidia-and-ibm-what-to-watch-when-the-market-opens-11626778707?mod=rss_markets_main\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.wsj.com/articles/space-race-nvidia-and-ibm-what-to-watch-when-the-market-opens-11626778707?mod=rss_markets_main","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159359820","content_text":"Stock futures are higher after Monday’s slide on Wall Street.\n\n\nTo the moon! Well, not quite, butinto space at leasttoday forJeff Bezos,the billionaire baron of ecommerce. Also not going to the moon isAmazonAMZN-1.19%stock, though it is 0.3% up premarket on Tuesday morning.\n\nOne reason for Mr. Bezos’s rocket ride is the more earthly goal of winning government contracts for the kind of less thrilling scientific projects the provide reliable revenue. His Blue Origin company is playing catch-up withElon Musk’s SpaceX.\nMr. Musk’s electric vehicle makerTesla,TSLA-1.55%is getting a bit of a boost Tuesday morning ahead of the open, rising 1% premarket. It is also gaining more attention on the message boards among day traders, according to Topstonks.com. The company reports earnings next Monday and tends to see its stock rise in the days ahead as investors start hoping for exciting announcements.\nIn the wider markets, U.S. stock futures are trending higher ahead of the open following Monday’s broad selloff. S&P 500 futures and Dow futures are up 0.3%, and Nasdaq-100 futures are up 0.4%.\nNasdaq the company, not the index, is itself rising premarket, up 1%, after TheWall Street Journal’s exclusivethat it will spin out its Private Market for shares in start-ups that trade among some investors before an initial public offering. The business will go into a standalone joint venture company and get investment from three Wall Street banks and SVB Financial Group, a tech specialist bank.\nNvidiaNVDA-1.30%is down 0.8% on large volumes following a  3.4% rise Monday. The shares are up nearly 80% over the past year, putting the chip makerinto the top 10list of U.S. public companies. It also executed its four-for-one stock split overnight, which has given some investorsmore ways to trade the stock-performance.\nInternational Business MachinesIBM+0.54%is up 2.8% ahead of the open on Tuesday after turning in decent second-quarter numbers Monday after the close. The computing group’s efforts to refocus on cloud-based computing and spin off its old-fashioned IT services business is winning fans among investors. At the same time, it has benefitted from companies beginning to invest again as the economy reopens.\n\n\nAdvanced Micro DevicesAMD+1.43%is rising up the chat charts on social media platforms, according to Topstonks.com, gaining popularity among retail traders. Its shares are up 0.4% premarket on good volumes following a 0.8% rise Monday.\nGrowing chatter and chunky volumes Tuesday morning for another perennial retail favourite:AMC Entertainment.AMC-3.16%The cinema chain’s shares have taken a bit of a beating so far this month, but they are 1.7% higher premarket Tuesday.\nZoom Video CommunicationsZM-3.50%is bouncing slightly Tuesday morning, up 0.4% in premarket trading after a 2.2% drop on Monday when it revealed it would buy customer service software firmFive9.FIVN-3.04%The target’s shares jumped nearly 6% Monday, are down 0.3% premarket.\nShares in big U.S. investments banks, which all took a knock Monday with the drop in financial markets, look set to rebound a bit Tuesday:Goldman SachsGS+2.91%andJPMorgan ChaseJPM+2.66%are both up about 0.3%, while andMorgan StanleyMS+1.64%up about 0.5% in premarket trading.\nBitcoin dropped below $30,000 Tuesday for the first time in a month.\nNetflix,NFLX-0.33%United AirlinesUAL-0.71%andChipotle Mexican GrillCMG-0.63%are due to report earnings after Tuesday’s close.\n\n\n\nStocks, commodities and other financial marketstook a stumbleMonday on growing concerns about the strength of the post-Covid-19 global recovery.\n\nCorrections & Amplifications\nNvidia shares rose 3.4% on Monday, July 19. An earlier version of this article incorrectly said that they rose 15%. A separate version of the article incorrectly said they rose 3%. (Corrected on Aug. 6)","news_type":1},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834262776,"gmtCreate":1629807853695,"gmtModify":1676530137292,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/834262776","repostId":"2161208319","repostType":4,"repost":{"id":"2161208319","kind":"news","pubTimestamp":1629805385,"share":"https://ttm.financial/m/news/2161208319?lang=&edition=fundamental","pubTime":"2021-08-24 19:43","market":"us","language":"en","title":"Baidu's AI voice assistant Xiaodu closes funding at $5.1 billion valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2161208319","media":"Reuters","summary":"(Reuters) - Chinese tech giant Baidu Inc said on Tuesday its artificial intelligence (AI) voice assi","content":"<p>(Reuters) - Chinese tech giant <a href=\"https://laohu8.com/S/BIDU\">Baidu</a> Inc said on Tuesday its artificial intelligence (AI) voice assistant Xiaodu Technology has closed Series B financing at a $5.1 billion valuation.</p>\n<p>Xiaodu is the developer of DuerOS, a voice assistant system based on AI that supports television, speakers and other smart home appliances. It completed its Series A funding in November 2020 at a post-money valuation of $2.9 billion, said Baidu.</p>\n<p>Earlier in March, Baidu said that its AI chip unit Kunlun also completed a round of fundraising, which according to one source with direct knowledge of the matter valued the business at about $2 billion. </p>\n<p>Baidu said on Tuesday that after the transaction it would remain a majority shareholder.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baidu's AI voice assistant Xiaodu closes funding at $5.1 billion valuation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaidu's AI voice assistant Xiaodu closes funding at $5.1 billion valuation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 19:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/baidus-ai-voice-assistant-xiaodu-110841708.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Chinese tech giant Baidu Inc said on Tuesday its artificial intelligence (AI) voice assistant Xiaodu Technology has closed Series B financing at a $5.1 billion valuation.\nXiaodu is the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/baidus-ai-voice-assistant-xiaodu-110841708.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIDU":"百度"},"source_url":"https://finance.yahoo.com/news/baidus-ai-voice-assistant-xiaodu-110841708.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2161208319","content_text":"(Reuters) - Chinese tech giant Baidu Inc said on Tuesday its artificial intelligence (AI) voice assistant Xiaodu Technology has closed Series B financing at a $5.1 billion valuation.\nXiaodu is the developer of DuerOS, a voice assistant system based on AI that supports television, speakers and other smart home appliances. It completed its Series A funding in November 2020 at a post-money valuation of $2.9 billion, said Baidu.\nEarlier in March, Baidu said that its AI chip unit Kunlun also completed a round of fundraising, which according to one source with direct knowledge of the matter valued the business at about $2 billion. \nBaidu said on Tuesday that after the transaction it would remain a majority shareholder.","news_type":1},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893377344,"gmtCreate":1628242147288,"gmtModify":1703503818589,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/893377344","repostId":"2157432677","repostType":4,"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805040601,"gmtCreate":1627827848603,"gmtModify":1703496341798,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/805040601","repostId":"2155001152","repostType":4,"repost":{"id":"2155001152","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627675228,"share":"https://ttm.financial/m/news/2155001152?lang=&edition=fundamental","pubTime":"2021-07-31 04:00","market":"us","language":"en","title":"Wall Street declines with Amazon; S&P 500 posts gains for month","url":"https://stock-news.laohu8.com/highlight/detail?id=2155001152","media":"Reuters","summary":"U.S. consumer spending rises in June, inflation increases . NEW YORK, July 30  - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&P 500 still posted a sixth straight month of gains.Amazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.Shares of oth","content":"<ul>\n <li>Pinterest sinks on stalled U.S. user growth</li>\n <li>U.S. consumer spending rises in June, inflation increases (Updates to close)</li>\n</ul>\n<p>NEW YORK, July 30 (Reuters) - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&amp;P 500 still posted a sixth straight month of gains.</p>\n<p>Amazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.</p>\n<p>Shares of other internet and tech giants that did well during the lockdowns of last year, including Google parent Alphabet Inc and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc, were mostly lower.</p>\n<p>\"Overall earnings have been good. But Amazon ... and some of last year's winners are taking some of the air out of the market today,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"This market has been driven by big tech and when tech does well, the market seems to go right along with it, and when it doesn't,\" it falls.</p>\n<p>Data on Friday showed U.S. consumer spending rose more than expected in June, although annual inflation accelerated further above the Federal Reserve's 2% target.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 146.36 points, or 0.42%, to 34,938.17, the S&amp;P 500 lost 23.58 points, or 0.53%, to 4,395.57 and the Nasdaq Composite dropped 101.51 points, or 0.69%, to 14,676.76.</p>\n<p>Strong earnings and the continued rebound in the U.S. economy have helped to support stocks this month, but the rapid spread of the Delta variant of the coronavirus and rising inflation have been concerns.</p>\n<p>\"There are still some distant jitters, whispers about the Delta variant, about cases rising, and I think some underlying worries about a slowdown of the reopenings and possible reversal,\" Dollarhide said.</p>\n<p>Also on the earnings front, Pampers maker Procter &amp; Gamble Co rose as it forecast higher core earnings for this year, and U.S.-listed shares of Canada's <a href=\"https://laohu8.com/S/QSR\">Restaurant Brands International Inc</a> jumped after the Burger King owner beat estimates for quarterly profit.</p>\n<p>Pinterest Inc, however, plunged after saying U.S. user growth was decelerating as people who used the platform for crafts and DIY projects during the height of the pandemic were stepping out more.</p>\n<p>Caterpillar Inc shares also fell, even though the company posted a rise in second-quarter adjusted profit on the back of a recovery in global economic activity.</p>\n<p>Results on the quarter overall have been much stronger than expected, with about 89% of the reports beating analysts' estimates on earnings, according to IBES data from Refinitiv. Earnings are now expected to have climbed 89.8% in the second quarter versus forecasts of 65.4% at the start of July. (Reporting by Caroline Valetkevitch in New York Additional reporting by Sagarika Jaisinghani in Bengaluru Editing by Arun Koyyur and Matthew Lewis)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street declines with Amazon; S&P 500 posts gains for month</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street declines with Amazon; S&P 500 posts gains for month\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-31 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Pinterest sinks on stalled U.S. user growth</li>\n <li>U.S. consumer spending rises in June, inflation increases (Updates to close)</li>\n</ul>\n<p>NEW YORK, July 30 (Reuters) - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&amp;P 500 still posted a sixth straight month of gains.</p>\n<p>Amazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.</p>\n<p>Shares of other internet and tech giants that did well during the lockdowns of last year, including Google parent Alphabet Inc and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc, were mostly lower.</p>\n<p>\"Overall earnings have been good. But Amazon ... and some of last year's winners are taking some of the air out of the market today,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"This market has been driven by big tech and when tech does well, the market seems to go right along with it, and when it doesn't,\" it falls.</p>\n<p>Data on Friday showed U.S. consumer spending rose more than expected in June, although annual inflation accelerated further above the Federal Reserve's 2% target.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 146.36 points, or 0.42%, to 34,938.17, the S&amp;P 500 lost 23.58 points, or 0.53%, to 4,395.57 and the Nasdaq Composite dropped 101.51 points, or 0.69%, to 14,676.76.</p>\n<p>Strong earnings and the continued rebound in the U.S. economy have helped to support stocks this month, but the rapid spread of the Delta variant of the coronavirus and rising inflation have been concerns.</p>\n<p>\"There are still some distant jitters, whispers about the Delta variant, about cases rising, and I think some underlying worries about a slowdown of the reopenings and possible reversal,\" Dollarhide said.</p>\n<p>Also on the earnings front, Pampers maker Procter &amp; Gamble Co rose as it forecast higher core earnings for this year, and U.S.-listed shares of Canada's <a href=\"https://laohu8.com/S/QSR\">Restaurant Brands International Inc</a> jumped after the Burger King owner beat estimates for quarterly profit.</p>\n<p>Pinterest Inc, however, plunged after saying U.S. user growth was decelerating as people who used the platform for crafts and DIY projects during the height of the pandemic were stepping out more.</p>\n<p>Caterpillar Inc shares also fell, even though the company posted a rise in second-quarter adjusted profit on the back of a recovery in global economic activity.</p>\n<p>Results on the quarter overall have been much stronger than expected, with about 89% of the reports beating analysts' estimates on earnings, according to IBES data from Refinitiv. Earnings are now expected to have climbed 89.8% in the second quarter versus forecasts of 65.4% at the start of July. (Reporting by Caroline Valetkevitch in New York Additional reporting by Sagarika Jaisinghani in Bengaluru Editing by Arun Koyyur and Matthew Lewis)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SSO":"两倍做多标普500ETF","OEX":"标普100","COMP":"Compass, Inc.","AMZN":"亚马逊","CAT":"卡特彼勒","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF",".SPX":"S&P 500 Index","UPRO":"三倍做多标普500ETF","OEF":"标普100指数ETF-iShares","SDS":"两倍做空标普500ETF","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155001152","content_text":"Pinterest sinks on stalled U.S. user growth\nU.S. consumer spending rises in June, inflation increases (Updates to close)\n\nNEW YORK, July 30 (Reuters) - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&P 500 still posted a sixth straight month of gains.\nAmazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.\nShares of other internet and tech giants that did well during the lockdowns of last year, including Google parent Alphabet Inc and Facebook Inc, were mostly lower.\n\"Overall earnings have been good. But Amazon ... and some of last year's winners are taking some of the air out of the market today,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"This market has been driven by big tech and when tech does well, the market seems to go right along with it, and when it doesn't,\" it falls.\nData on Friday showed U.S. consumer spending rose more than expected in June, although annual inflation accelerated further above the Federal Reserve's 2% target.\nUnofficially, the Dow Jones Industrial Average fell 146.36 points, or 0.42%, to 34,938.17, the S&P 500 lost 23.58 points, or 0.53%, to 4,395.57 and the Nasdaq Composite dropped 101.51 points, or 0.69%, to 14,676.76.\nStrong earnings and the continued rebound in the U.S. economy have helped to support stocks this month, but the rapid spread of the Delta variant of the coronavirus and rising inflation have been concerns.\n\"There are still some distant jitters, whispers about the Delta variant, about cases rising, and I think some underlying worries about a slowdown of the reopenings and possible reversal,\" Dollarhide said.\nAlso on the earnings front, Pampers maker Procter & Gamble Co rose as it forecast higher core earnings for this year, and U.S.-listed shares of Canada's Restaurant Brands International Inc jumped after the Burger King owner beat estimates for quarterly profit.\nPinterest Inc, however, plunged after saying U.S. user growth was decelerating as people who used the platform for crafts and DIY projects during the height of the pandemic were stepping out more.\nCaterpillar Inc shares also fell, even though the company posted a rise in second-quarter adjusted profit on the back of a recovery in global economic activity.\nResults on the quarter overall have been much stronger than expected, with about 89% of the reports beating analysts' estimates on earnings, according to IBES data from Refinitiv. Earnings are now expected to have climbed 89.8% in the second quarter versus forecasts of 65.4% at the start of July. (Reporting by Caroline Valetkevitch in New York Additional reporting by Sagarika Jaisinghani in Bengaluru Editing by Arun Koyyur and Matthew Lewis)","news_type":1},"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898001499,"gmtCreate":1628438218211,"gmtModify":1703506241848,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Yes heading there","listText":"Yes heading there","text":"Yes heading there","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/898001499","repostId":"1159872041","repostType":4,"repost":{"id":"1159872041","kind":"news","pubTimestamp":1628385224,"share":"https://ttm.financial/m/news/1159872041?lang=&edition=fundamental","pubTime":"2021-08-08 09:13","market":"us","language":"en","title":"Tesla Stock: Headed to $1,200?","url":"https://stock-news.laohu8.com/highlight/detail?id=1159872041","media":"Motley Fool","summary":"Tesla deliveries more than doubled year over year in Q2.Rising demand for electric vehicles could benefit Tesla.Investors should exercise caution when it comes to analysts' price targets.It's been a wild year for Teslastock. When the year started, shares initially surged more than 20%. But the stock has now given up all of those gains, with a year-to-date return of negative 1%. This means the stock has significantly underperformed the S&P 500's 18% gain this year.In February,Piper Sandler analys","content":"<p><b>Key Points</b></p>\n<ul>\n <li>Tesla deliveries more than doubled year over year in Q2.</li>\n <li>Rising demand for electric vehicles could benefit Tesla.</li>\n <li>Investors should exercise caution when it comes to analysts' price targets.</li>\n</ul>\n<p>It's been a wild year for&nbsp;<b>Tesla</b>(NASDAQ:TSLA)stock. When the year started, shares initially surged more than 20%. But the stock has now given up all of those gains, with a year-to-date return of negative 1%. This means the stock has significantly underperformed the&nbsp;<b>S&amp;P 500</b>'s 18% gain this year.</p>\n<p>But one analyst thinks the stock could take off.</p>\n<p><b>\"We still really like this stock.\"</b></p>\n<p>In February,<b>Piper Sandler</b>&nbsp;analyst Alexander Pottermade a bold call, boosting his 12-month price target for thegrowth stockfrom $515 to $1,200. He said Tesla deliveries could increase from 500,000 vehicles in 2020 to nearly 900,000 this year. Of course, this projection was made before global supply shortages worsened. Nevertheless, Tesla is growing extremely rapidly. The company's second-quarter deliveries more than doubled compared to the year-ago quarter, rising to 201,304.</p>\n<p>Following Tesla's second-quarter earnings release late last month, the analyst reiterated this target, noting that the company looks poised to benefit from market share gains, the monetization of the company's Autopilot software, and \"underappreciated opportunities\" in Tesla's energy business, which includes revenue from battery energy storage and solar energy generation products.</p>\n<p>Further, Potter pointed to Tesla's strong second-quarter operating margin of 11%, which he expects will see incremental improvement from Tesla's recently launched Autopilot subscription.</p>\n<p>On Aug. 3, Potter once again reiterated an overweight rating on the stock and a $1,200 price target, saying \"We still really like this stock.\" He pointed to growing demand for battery electric vehicles overall.</p>\n<p><b>So what gives?</b></p>\n<p>If shares could truly rise to $1,200, why do so many investors seem to think the stock is worth so much less (based on the stock's price of just under $700 at the time of this writing). After all, if $1,200 was generally viewed by investors as a likely outcome for Tesla stock within the next 12 months, shares would be trading significantly higher today.</p>\n<p>The issue boils down to the stock's forward-looking valuation. With a price-to-earnings ratio of about 370 at the time of this writing, Tesla shares are largely priced for strong growth for years to come. Since the company's valuation is based largely on profits far into the future, slight variances in views for Tesla's future growth trajectory yield dramatically different assumptions about the stock's intrinsic value today.</p>\n<p>Investors, therefore, shouldn't be quick to buy Tesla stock just because one analyst has a high price target for shares. Still, Potter does notably have some good points about Tesla's strong business momentum. Even Tesla itself reiterated guidance for vehicle deliveries to grow more than 50% this year -- and that guidance was provided during a time that many companies around the world (including Tesla) are negatively impacted by supply chain shortages. Further, Tesla management noted in its second-quarter update that demand for its vehicles was at an all-time high going into Q3.</p>\n<p>While a $1,200 price target for Tesla stock would be difficult to justify, shares may be trading low enough for investors to start a small position in the stock.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock: Headed to $1,200?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock: Headed to $1,200?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-08 09:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/07/tesla-stock-headed-to-1200/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nTesla deliveries more than doubled year over year in Q2.\nRising demand for electric vehicles could benefit Tesla.\nInvestors should exercise caution when it comes to analysts' price targets...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/07/tesla-stock-headed-to-1200/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/08/07/tesla-stock-headed-to-1200/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159872041","content_text":"Key Points\n\nTesla deliveries more than doubled year over year in Q2.\nRising demand for electric vehicles could benefit Tesla.\nInvestors should exercise caution when it comes to analysts' price targets.\n\nIt's been a wild year for Tesla(NASDAQ:TSLA)stock. When the year started, shares initially surged more than 20%. But the stock has now given up all of those gains, with a year-to-date return of negative 1%. This means the stock has significantly underperformed the S&P 500's 18% gain this year.\nBut one analyst thinks the stock could take off.\n\"We still really like this stock.\"\nIn February,Piper Sandler analyst Alexander Pottermade a bold call, boosting his 12-month price target for thegrowth stockfrom $515 to $1,200. He said Tesla deliveries could increase from 500,000 vehicles in 2020 to nearly 900,000 this year. Of course, this projection was made before global supply shortages worsened. Nevertheless, Tesla is growing extremely rapidly. The company's second-quarter deliveries more than doubled compared to the year-ago quarter, rising to 201,304.\nFollowing Tesla's second-quarter earnings release late last month, the analyst reiterated this target, noting that the company looks poised to benefit from market share gains, the monetization of the company's Autopilot software, and \"underappreciated opportunities\" in Tesla's energy business, which includes revenue from battery energy storage and solar energy generation products.\nFurther, Potter pointed to Tesla's strong second-quarter operating margin of 11%, which he expects will see incremental improvement from Tesla's recently launched Autopilot subscription.\nOn Aug. 3, Potter once again reiterated an overweight rating on the stock and a $1,200 price target, saying \"We still really like this stock.\" He pointed to growing demand for battery electric vehicles overall.\nSo what gives?\nIf shares could truly rise to $1,200, why do so many investors seem to think the stock is worth so much less (based on the stock's price of just under $700 at the time of this writing). After all, if $1,200 was generally viewed by investors as a likely outcome for Tesla stock within the next 12 months, shares would be trading significantly higher today.\nThe issue boils down to the stock's forward-looking valuation. With a price-to-earnings ratio of about 370 at the time of this writing, Tesla shares are largely priced for strong growth for years to come. Since the company's valuation is based largely on profits far into the future, slight variances in views for Tesla's future growth trajectory yield dramatically different assumptions about the stock's intrinsic value today.\nInvestors, therefore, shouldn't be quick to buy Tesla stock just because one analyst has a high price target for shares. Still, Potter does notably have some good points about Tesla's strong business momentum. Even Tesla itself reiterated guidance for vehicle deliveries to grow more than 50% this year -- and that guidance was provided during a time that many companies around the world (including Tesla) are negatively impacted by supply chain shortages. Further, Tesla management noted in its second-quarter update that demand for its vehicles was at an all-time high going into Q3.\nWhile a $1,200 price target for Tesla stock would be difficult to justify, shares may be trading low enough for investors to start a small position in the stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807734157,"gmtCreate":1628056708179,"gmtModify":1703500411771,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/807734157","repostId":"1177585640","repostType":4,"repost":{"id":"1177585640","kind":"news","pubTimestamp":1628056440,"share":"https://ttm.financial/m/news/1177585640?lang=&edition=fundamental","pubTime":"2021-08-04 13:54","market":"us","language":"en","title":"Why Clean Energy Fuels Has Plenty of Work To Do","url":"https://stock-news.laohu8.com/highlight/detail?id=1177585640","media":"InvestorPlace","summary":"Clean Energy Fuels history of low to zero margins will keep the stock down unless they turn things a","content":"<p>Clean Energy Fuels history of low to zero margins will keep the stock down unless they turn things around</p>\n<p>Yes, it’s possible to invest in cow poo — or at least the product that is derived from it. Renewable natural gas (RNG) is a transportation fuel made from organic waste, primarily from cattle. Once it’s purified, this biomethane is chemically identical to the main ingredient in the fossil-based natural gas that comes out of a stove or heats residential water. The use of RNGs drastically reduces carbon emissions, and unlike conventional natural gas, RNG is not a fossil fuel and does not involve drilling. That said, the leader in this sector is&nbsp;<b>Clean Energy Fuels</b>(NASDAQ:<b><u>CLNE</u></b>) — but CLNE stock may lose its one-year gains of the firm doesn’t figure things out.</p>\n<p>Overall, Clean Energy Fuels provides natural gas as an alternative fuel for vehicle fleets and related fueling solutions, primarily in the United States and Canada. It supplies RNG, compressed natural gas (CNG) and liquefied natural gas (LNG) for light, medium, and heavy-duty vehicles. Additionally, the company offers operation and maintenance services for public and private vehicle fleet customer stations.</p>\n<p>Moreover, the company also designs, builds, operates and maintains fueling stations. It also sells and services compressors and other equipment that are used in fueling stations, and provides assessment, design and modification solutions to offer operators with code-compliant service and maintenance facilities for natural gas vehicle fleets.</p>\n<p>Collectively, Clean Energy Fuels serves heavy-duty trucking, airports, refuse, public transit, industrial, and institutional energy users, as well as government fleets. As of December 31, 2020, it served approximately&nbsp;1,000 fleet customers&nbsp;operating approximately 48,000 vehicles. And it also owned, operated, or supplied approximately 565 fueling stations in 39 states in the United States and five provinces in Canada.</p>\n<p>The Opportunity and Benefit of Clean Energy</p>\n<p>According to the company, livestock manure and landfills account for 27% of methane emissions in the U.S. That said, this is the original source of where Clean Energy Fuels gets its RNG.</p>\n<p>When organic matter decays, it naturally produces methane — one of the greenhouse gases most detrimental to the environment. So, by capturing the methane, the company prevents it from entering and damaging the atmosphere. Then, they can then turn it into clean fuel for the transportation industry. That said, the transportation industry — as a whole — was responsible for&nbsp;29% of the total greenhouse gas emissions in the U.S.&nbsp;in 2019.</p>\n<p>This all sounds great, so there must be a catch. Well, the catch is that Clean Energy Fuels has been around a very long time, but still cant generate consistent high margin profits. That said, here is a very-detailed explanation of why the company is struggling in that department:</p>\n<blockquote>\n “…The only logical explanation is that Clean Energy&nbsp;owns a very small percentage&nbsp;of the 540 fueling stations spread across the USA. It operates, maintains and supplies the fueling station with natural gases at commodity prices plus charges for transportation, compression, storage and maintenance. While Clean Energy has adopted an excellent business model, unfortunately, it operates in an area of the value chain with minimal operating margins.”\n</blockquote>\n<blockquote>\n “Over the past five years, Clean Energy Fuels has consistently failed to produce positive operating margins. While SG&amp;A (selling, general and administrative) expenses have fallen by roughly $5 million each of the previous three years, it hasn’t resulted in sustained positive margins. To help hide the negative operating and profit margins, management tends to focus on adjusted EBITDA. This is simply an alternate accounting method, which hides real world expenses and shouldn’t be considered a route to profitability.”\n</blockquote>\n<p>Furthermore, analyst earnings per share (EPS) estimates for 2021 and 2022 are only 3 cents and 4 cents, respectively, despite revenue estimates of about $323 and $364 million for the same period. So, although transportation issues were and are abundant during the novel coronavirus pandemic, the profitability issues don’t seem to be subsiding for Clean Energy Fuels.</p>\n<p><b>Bottom Line on CLNE Stock</b></p>\n<p>As a whole, Clean Energy stock was a Reddit meme driven favorite earlier in the year. In fact, shares are up more than 200% over the past year after hitting a high of $19.79 per share in February.</p>\n<p>However, CLNE stock has really taken a tumble in the months since — losing nearly 60% of its value. And unless the company offers a clear path to much higher margins, the stock will likely return to its long-term trading range of $2 to $3.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Clean Energy Fuels Has Plenty of Work To Do</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Clean Energy Fuels Has Plenty of Work To Do\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 13:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/08/clean-energy-fuels-clne-stock-continues-to-hunt-for-higher-margins/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Clean Energy Fuels history of low to zero margins will keep the stock down unless they turn things around\nYes, it’s possible to invest in cow poo — or at least the product that is derived from it. ...</p>\n\n<a href=\"https://investorplace.com/2021/08/clean-energy-fuels-clne-stock-continues-to-hunt-for-higher-margins/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLNE":"Clean Energy Fuels Corp"},"source_url":"https://investorplace.com/2021/08/clean-energy-fuels-clne-stock-continues-to-hunt-for-higher-margins/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177585640","content_text":"Clean Energy Fuels history of low to zero margins will keep the stock down unless they turn things around\nYes, it’s possible to invest in cow poo — or at least the product that is derived from it. Renewable natural gas (RNG) is a transportation fuel made from organic waste, primarily from cattle. Once it’s purified, this biomethane is chemically identical to the main ingredient in the fossil-based natural gas that comes out of a stove or heats residential water. The use of RNGs drastically reduces carbon emissions, and unlike conventional natural gas, RNG is not a fossil fuel and does not involve drilling. That said, the leader in this sector is Clean Energy Fuels(NASDAQ:CLNE) — but CLNE stock may lose its one-year gains of the firm doesn’t figure things out.\nOverall, Clean Energy Fuels provides natural gas as an alternative fuel for vehicle fleets and related fueling solutions, primarily in the United States and Canada. It supplies RNG, compressed natural gas (CNG) and liquefied natural gas (LNG) for light, medium, and heavy-duty vehicles. Additionally, the company offers operation and maintenance services for public and private vehicle fleet customer stations.\nMoreover, the company also designs, builds, operates and maintains fueling stations. It also sells and services compressors and other equipment that are used in fueling stations, and provides assessment, design and modification solutions to offer operators with code-compliant service and maintenance facilities for natural gas vehicle fleets.\nCollectively, Clean Energy Fuels serves heavy-duty trucking, airports, refuse, public transit, industrial, and institutional energy users, as well as government fleets. As of December 31, 2020, it served approximately 1,000 fleet customers operating approximately 48,000 vehicles. And it also owned, operated, or supplied approximately 565 fueling stations in 39 states in the United States and five provinces in Canada.\nThe Opportunity and Benefit of Clean Energy\nAccording to the company, livestock manure and landfills account for 27% of methane emissions in the U.S. That said, this is the original source of where Clean Energy Fuels gets its RNG.\nWhen organic matter decays, it naturally produces methane — one of the greenhouse gases most detrimental to the environment. So, by capturing the methane, the company prevents it from entering and damaging the atmosphere. Then, they can then turn it into clean fuel for the transportation industry. That said, the transportation industry — as a whole — was responsible for 29% of the total greenhouse gas emissions in the U.S. in 2019.\nThis all sounds great, so there must be a catch. Well, the catch is that Clean Energy Fuels has been around a very long time, but still cant generate consistent high margin profits. That said, here is a very-detailed explanation of why the company is struggling in that department:\n\n “…The only logical explanation is that Clean Energy owns a very small percentage of the 540 fueling stations spread across the USA. It operates, maintains and supplies the fueling station with natural gases at commodity prices plus charges for transportation, compression, storage and maintenance. While Clean Energy has adopted an excellent business model, unfortunately, it operates in an area of the value chain with minimal operating margins.”\n\n\n “Over the past five years, Clean Energy Fuels has consistently failed to produce positive operating margins. While SG&A (selling, general and administrative) expenses have fallen by roughly $5 million each of the previous three years, it hasn’t resulted in sustained positive margins. To help hide the negative operating and profit margins, management tends to focus on adjusted EBITDA. This is simply an alternate accounting method, which hides real world expenses and shouldn’t be considered a route to profitability.”\n\nFurthermore, analyst earnings per share (EPS) estimates for 2021 and 2022 are only 3 cents and 4 cents, respectively, despite revenue estimates of about $323 and $364 million for the same period. So, although transportation issues were and are abundant during the novel coronavirus pandemic, the profitability issues don’t seem to be subsiding for Clean Energy Fuels.\nBottom Line on CLNE Stock\nAs a whole, Clean Energy stock was a Reddit meme driven favorite earlier in the year. In fact, shares are up more than 200% over the past year after hitting a high of $19.79 per share in February.\nHowever, CLNE stock has really taken a tumble in the months since — losing nearly 60% of its value. And unless the company offers a clear path to much higher margins, the stock will likely return to its long-term trading range of $2 to $3.","news_type":1},"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899101279,"gmtCreate":1628166081291,"gmtModify":1703502391433,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899101279","repostId":"2157395984","repostType":4,"repost":{"id":"2157395984","kind":"highlight","pubTimestamp":1628165160,"share":"https://ttm.financial/m/news/2157395984?lang=&edition=fundamental","pubTime":"2021-08-05 20:06","market":"us","language":"en","title":"Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2157395984","media":"Motley Fool","summary":"Projecting over $33 billion in COVID-19 vaccine revenue alone in 2021, CEO Albert Bourla wants to beef up Pfizer's pipeline.","content":"<p>Speaking back in May on his company's Q1 2021 earnings call, <b>Pfizer</b> (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] ... in the second part of the decade.\" &nbsp;With pre-tax profit on its COVID-19 vaccine in the high 20% range and Bourla's company guiding for $78 billion to $80 billion in revenue for 2021 (with more than $33 billion of that coming from the vaccine), there's certainly money to be spent on acquisitions. Let's look at three potential candidates that could help Pfizer to further secure its future.</p>\n<h3>The budding oncology research machine</h3>\n<p>If Pfizer wants to fill its pipeline with precision-medicine oncology drugs for the next decade, perhaps it will consider <b>Blueprint Medicines</b> (NASDAQ:BPMC). This $5 billion biotech is the first and only company to have two internally discovered and developed medicines that received U.S. Food and Drug Administration (FDA) approval within a decade of its founding.</p>\n<p><img src=\"https://static.tigerbbs.com/0cba561a33b8fd037c17212c807d1ccb\" tg-width=\"700\" tg-height=\"438\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>Its first oncology drug, Gavreto, is a once-a-day oral medication for non-small cell lung cancer, as well as certain types of thyroid cancer with a mutation in a specific gene called RET. Altogether, these markets add up to about 6,000 patients annually in the U.S.</p>\n<p>At a cost of $231,000 per patient per year, that's a $1.3 billion addressable market for which Blueprint and partner <b>Roche</b> will split costs and profits 50-50 in the U.S. While Gavreto competes with <b>Eli Lilly</b>'s&nbsp;Retevmo in this market, the Roche-Blueprint product currently has a 40% share of the RET-inhibitor space, despite being the second <a href=\"https://laohu8.com/S/AONE.U\">one</a> to the party.</p>\n<p>The precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. <b>AstraZeneca</b>'s Tagrisso, which has a similar target, hauled in a whopping $4.3 billion-plus in FY 2020.</p>\n<p>While there is some tough competition out there, Blueprint has shown it can quickly bring drugs to market. With plenty of financial support and a large seasoned sales force already in place, Pfizer could rapidly capitalize on a buyout of this $5 billion business. And we haven't even mentioned Blueprint's other approved drug, which is for a rare disease called mastocytosis&nbsp;and has an addressable market in the U.S. of at least $800 million.</p>\n<h3>The safe rare-disease tuck-in</h3>\n<p>When<b> Aurinia Pharmaceuticals</b>' (NASDAQ:AUPH) Lupkynis was approved in January, it became the first oral therapy approved for lupus nephritis that doesn't require monitoring of drug levels. Lupus nephritis is an autoimmune disorder that's especially harsh on the kidneys, with approximately 10% to 30% of patients experiencing kidney failure within 15 years, despite current therapies.</p>\n<p>This disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likely&nbsp;to improve kidney function. In fact, 40.8% of patients see improvements in renal function after 52 treatments with Lupkynis, versus 22.5% receiving standard-of-care treatment alone.</p>\n<p>The autoimmune-focused biotech expects an average annualized net revenue per patient of approximately $65,000. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion.</p>\n<p>Even better, this doesn't even get into the potential for Lupkynis to treat other autoimmune diseases. Pfizer already has multiple compounds aimed at various autoimmune conditions, and this $1.8 billion company seems like an obvious tuck-in acquisition for the pharma giant. It has an approved drug with a blockbuster addressable market, and that drug may have optionality for other autoimmune conditions as well (though it's not actively being studied in other diseases at the moment).</p>\n<h3>The next frontier in COVID treatment</h3>\n<p>With COVID-19 cases rising worldwide, there's a pressing need for an efficacious oral therapy that can be administered not only to hospitalized patients but also to those well enough to be given a prescription as outpatients. Pharma <b>Atea Pharmaceuticals</b> (NASDAQ:AVIR)&nbsp;reported interim phase 2 results at the end of June showing that its lead COVID-19 oral treatment, AT-527, could rapidly reduce the viral load in COVID-19 patients.</p>\n<p>After two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. Atea partnered with Roche in October 2020 on AT-527, and the drug is now in an ongoing worldwide phase 3 trial with results due in the second half of 2021. After its raging success with <b>BioNTech </b>on their coronavirus vaccine, Pfizer may be willing to double down on partnerships in the COVID-19 space -- especially with Bourla's company raising its 2021 sales forecast of its partnered COVID-19 vaccine to $33.5 billion for the year.</p>\n<p>With Atea valued at just $2.1 billion yet having megablockbuster potential, there's a lot of upside for Pfizer. An Atea buyout also would provide a safety net should Pfizer's own oral combination therapy for COVID, which just entered phase 2/3 trials, fizzle out.</p>\n<p>If I were Albert Bourla, which would I choose? On July 22, Pfizer announced a global collaboration with Arvinas, which has a breast cancer treatment in phase 2 trials. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. Given this, the behemoth may not be looking for another oncology company right away. And despite impressive COVID-19 data from Atea, Pfizer has its own oral coronavirus treatment early in progress, though not quite as far along in clinical trials.</p>\n<p>That leaves Aurinia, which I believe to be the safest buy on the list for pharmaceutical investors -- Pfizer included. With a market cap of less than $2 billion and a potential blockbuster that has possible optionality into other autoimmune diseases, Aurinia looks undervalued and could find itself being acquired sooner rather than later.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-05 20:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Speaking back in May on his company's Q1 2021 earnings call, Pfizer (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157395984","content_text":"Speaking back in May on his company's Q1 2021 earnings call, Pfizer (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] ... in the second part of the decade.\"  With pre-tax profit on its COVID-19 vaccine in the high 20% range and Bourla's company guiding for $78 billion to $80 billion in revenue for 2021 (with more than $33 billion of that coming from the vaccine), there's certainly money to be spent on acquisitions. Let's look at three potential candidates that could help Pfizer to further secure its future.\nThe budding oncology research machine\nIf Pfizer wants to fill its pipeline with precision-medicine oncology drugs for the next decade, perhaps it will consider Blueprint Medicines (NASDAQ:BPMC). This $5 billion biotech is the first and only company to have two internally discovered and developed medicines that received U.S. Food and Drug Administration (FDA) approval within a decade of its founding.\n\nImage source: Getty Images.\nIts first oncology drug, Gavreto, is a once-a-day oral medication for non-small cell lung cancer, as well as certain types of thyroid cancer with a mutation in a specific gene called RET. Altogether, these markets add up to about 6,000 patients annually in the U.S.\nAt a cost of $231,000 per patient per year, that's a $1.3 billion addressable market for which Blueprint and partner Roche will split costs and profits 50-50 in the U.S. While Gavreto competes with Eli Lilly's Retevmo in this market, the Roche-Blueprint product currently has a 40% share of the RET-inhibitor space, despite being the second one to the party.\nThe precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. AstraZeneca's Tagrisso, which has a similar target, hauled in a whopping $4.3 billion-plus in FY 2020.\nWhile there is some tough competition out there, Blueprint has shown it can quickly bring drugs to market. With plenty of financial support and a large seasoned sales force already in place, Pfizer could rapidly capitalize on a buyout of this $5 billion business. And we haven't even mentioned Blueprint's other approved drug, which is for a rare disease called mastocytosis and has an addressable market in the U.S. of at least $800 million.\nThe safe rare-disease tuck-in\nWhen Aurinia Pharmaceuticals' (NASDAQ:AUPH) Lupkynis was approved in January, it became the first oral therapy approved for lupus nephritis that doesn't require monitoring of drug levels. Lupus nephritis is an autoimmune disorder that's especially harsh on the kidneys, with approximately 10% to 30% of patients experiencing kidney failure within 15 years, despite current therapies.\nThis disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likely to improve kidney function. In fact, 40.8% of patients see improvements in renal function after 52 treatments with Lupkynis, versus 22.5% receiving standard-of-care treatment alone.\nThe autoimmune-focused biotech expects an average annualized net revenue per patient of approximately $65,000. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion.\nEven better, this doesn't even get into the potential for Lupkynis to treat other autoimmune diseases. Pfizer already has multiple compounds aimed at various autoimmune conditions, and this $1.8 billion company seems like an obvious tuck-in acquisition for the pharma giant. It has an approved drug with a blockbuster addressable market, and that drug may have optionality for other autoimmune conditions as well (though it's not actively being studied in other diseases at the moment).\nThe next frontier in COVID treatment\nWith COVID-19 cases rising worldwide, there's a pressing need for an efficacious oral therapy that can be administered not only to hospitalized patients but also to those well enough to be given a prescription as outpatients. Pharma Atea Pharmaceuticals (NASDAQ:AVIR) reported interim phase 2 results at the end of June showing that its lead COVID-19 oral treatment, AT-527, could rapidly reduce the viral load in COVID-19 patients.\nAfter two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. Atea partnered with Roche in October 2020 on AT-527, and the drug is now in an ongoing worldwide phase 3 trial with results due in the second half of 2021. After its raging success with BioNTech on their coronavirus vaccine, Pfizer may be willing to double down on partnerships in the COVID-19 space -- especially with Bourla's company raising its 2021 sales forecast of its partnered COVID-19 vaccine to $33.5 billion for the year.\nWith Atea valued at just $2.1 billion yet having megablockbuster potential, there's a lot of upside for Pfizer. An Atea buyout also would provide a safety net should Pfizer's own oral combination therapy for COVID, which just entered phase 2/3 trials, fizzle out.\nIf I were Albert Bourla, which would I choose? On July 22, Pfizer announced a global collaboration with Arvinas, which has a breast cancer treatment in phase 2 trials. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. Given this, the behemoth may not be looking for another oncology company right away. And despite impressive COVID-19 data from Atea, Pfizer has its own oral coronavirus treatment early in progress, though not quite as far along in clinical trials.\nThat leaves Aurinia, which I believe to be the safest buy on the list for pharmaceutical investors -- Pfizer included. With a market cap of less than $2 billion and a potential blockbuster that has possible optionality into other autoimmune diseases, Aurinia looks undervalued and could find itself being acquired sooner rather than later.","news_type":1},"isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899101825,"gmtCreate":1628166054467,"gmtModify":1703502391594,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899101825","repostId":"2157395984","repostType":4,"repost":{"id":"2157395984","kind":"highlight","pubTimestamp":1628165160,"share":"https://ttm.financial/m/news/2157395984?lang=&edition=fundamental","pubTime":"2021-08-05 20:06","market":"us","language":"en","title":"Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2157395984","media":"Motley Fool","summary":"Projecting over $33 billion in COVID-19 vaccine revenue alone in 2021, CEO Albert Bourla wants to beef up Pfizer's pipeline.","content":"<p>Speaking back in May on his company's Q1 2021 earnings call, <b>Pfizer</b> (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] ... in the second part of the decade.\" &nbsp;With pre-tax profit on its COVID-19 vaccine in the high 20% range and Bourla's company guiding for $78 billion to $80 billion in revenue for 2021 (with more than $33 billion of that coming from the vaccine), there's certainly money to be spent on acquisitions. Let's look at three potential candidates that could help Pfizer to further secure its future.</p>\n<h3>The budding oncology research machine</h3>\n<p>If Pfizer wants to fill its pipeline with precision-medicine oncology drugs for the next decade, perhaps it will consider <b>Blueprint Medicines</b> (NASDAQ:BPMC). This $5 billion biotech is the first and only company to have two internally discovered and developed medicines that received U.S. Food and Drug Administration (FDA) approval within a decade of its founding.</p>\n<p><img src=\"https://static.tigerbbs.com/0cba561a33b8fd037c17212c807d1ccb\" tg-width=\"700\" tg-height=\"438\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>Its first oncology drug, Gavreto, is a once-a-day oral medication for non-small cell lung cancer, as well as certain types of thyroid cancer with a mutation in a specific gene called RET. Altogether, these markets add up to about 6,000 patients annually in the U.S.</p>\n<p>At a cost of $231,000 per patient per year, that's a $1.3 billion addressable market for which Blueprint and partner <b>Roche</b> will split costs and profits 50-50 in the U.S. While Gavreto competes with <b>Eli Lilly</b>'s&nbsp;Retevmo in this market, the Roche-Blueprint product currently has a 40% share of the RET-inhibitor space, despite being the second <a href=\"https://laohu8.com/S/AONE.U\">one</a> to the party.</p>\n<p>The precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. <b>AstraZeneca</b>'s Tagrisso, which has a similar target, hauled in a whopping $4.3 billion-plus in FY 2020.</p>\n<p>While there is some tough competition out there, Blueprint has shown it can quickly bring drugs to market. With plenty of financial support and a large seasoned sales force already in place, Pfizer could rapidly capitalize on a buyout of this $5 billion business. And we haven't even mentioned Blueprint's other approved drug, which is for a rare disease called mastocytosis&nbsp;and has an addressable market in the U.S. of at least $800 million.</p>\n<h3>The safe rare-disease tuck-in</h3>\n<p>When<b> Aurinia Pharmaceuticals</b>' (NASDAQ:AUPH) Lupkynis was approved in January, it became the first oral therapy approved for lupus nephritis that doesn't require monitoring of drug levels. Lupus nephritis is an autoimmune disorder that's especially harsh on the kidneys, with approximately 10% to 30% of patients experiencing kidney failure within 15 years, despite current therapies.</p>\n<p>This disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likely&nbsp;to improve kidney function. In fact, 40.8% of patients see improvements in renal function after 52 treatments with Lupkynis, versus 22.5% receiving standard-of-care treatment alone.</p>\n<p>The autoimmune-focused biotech expects an average annualized net revenue per patient of approximately $65,000. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion.</p>\n<p>Even better, this doesn't even get into the potential for Lupkynis to treat other autoimmune diseases. Pfizer already has multiple compounds aimed at various autoimmune conditions, and this $1.8 billion company seems like an obvious tuck-in acquisition for the pharma giant. It has an approved drug with a blockbuster addressable market, and that drug may have optionality for other autoimmune conditions as well (though it's not actively being studied in other diseases at the moment).</p>\n<h3>The next frontier in COVID treatment</h3>\n<p>With COVID-19 cases rising worldwide, there's a pressing need for an efficacious oral therapy that can be administered not only to hospitalized patients but also to those well enough to be given a prescription as outpatients. Pharma <b>Atea Pharmaceuticals</b> (NASDAQ:AVIR)&nbsp;reported interim phase 2 results at the end of June showing that its lead COVID-19 oral treatment, AT-527, could rapidly reduce the viral load in COVID-19 patients.</p>\n<p>After two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. Atea partnered with Roche in October 2020 on AT-527, and the drug is now in an ongoing worldwide phase 3 trial with results due in the second half of 2021. After its raging success with <b>BioNTech </b>on their coronavirus vaccine, Pfizer may be willing to double down on partnerships in the COVID-19 space -- especially with Bourla's company raising its 2021 sales forecast of its partnered COVID-19 vaccine to $33.5 billion for the year.</p>\n<p>With Atea valued at just $2.1 billion yet having megablockbuster potential, there's a lot of upside for Pfizer. An Atea buyout also would provide a safety net should Pfizer's own oral combination therapy for COVID, which just entered phase 2/3 trials, fizzle out.</p>\n<p>If I were Albert Bourla, which would I choose? On July 22, Pfizer announced a global collaboration with Arvinas, which has a breast cancer treatment in phase 2 trials. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. Given this, the behemoth may not be looking for another oncology company right away. And despite impressive COVID-19 data from Atea, Pfizer has its own oral coronavirus treatment early in progress, though not quite as far along in clinical trials.</p>\n<p>That leaves Aurinia, which I believe to be the safest buy on the list for pharmaceutical investors -- Pfizer included. With a market cap of less than $2 billion and a potential blockbuster that has possible optionality into other autoimmune diseases, Aurinia looks undervalued and could find itself being acquired sooner rather than later.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-05 20:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Speaking back in May on his company's Q1 2021 earnings call, Pfizer (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/08/05/pfizer-ceo-wants-to-go-shopping-3-potential-compan/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157395984","content_text":"Speaking back in May on his company's Q1 2021 earnings call, Pfizer (NYSE:PFE) CEO Albert Bourla stated, \"You should expect to see a lot of ... business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] ... in the second part of the decade.\"  With pre-tax profit on its COVID-19 vaccine in the high 20% range and Bourla's company guiding for $78 billion to $80 billion in revenue for 2021 (with more than $33 billion of that coming from the vaccine), there's certainly money to be spent on acquisitions. Let's look at three potential candidates that could help Pfizer to further secure its future.\nThe budding oncology research machine\nIf Pfizer wants to fill its pipeline with precision-medicine oncology drugs for the next decade, perhaps it will consider Blueprint Medicines (NASDAQ:BPMC). This $5 billion biotech is the first and only company to have two internally discovered and developed medicines that received U.S. Food and Drug Administration (FDA) approval within a decade of its founding.\n\nImage source: Getty Images.\nIts first oncology drug, Gavreto, is a once-a-day oral medication for non-small cell lung cancer, as well as certain types of thyroid cancer with a mutation in a specific gene called RET. Altogether, these markets add up to about 6,000 patients annually in the U.S.\nAt a cost of $231,000 per patient per year, that's a $1.3 billion addressable market for which Blueprint and partner Roche will split costs and profits 50-50 in the U.S. While Gavreto competes with Eli Lilly's Retevmo in this market, the Roche-Blueprint product currently has a 40% share of the RET-inhibitor space, despite being the second one to the party.\nThe precision-medicine company also has two candidates entering phase 1 studies for non-small cell lung cancer with mutations within a specific gene called EGFR. AstraZeneca's Tagrisso, which has a similar target, hauled in a whopping $4.3 billion-plus in FY 2020.\nWhile there is some tough competition out there, Blueprint has shown it can quickly bring drugs to market. With plenty of financial support and a large seasoned sales force already in place, Pfizer could rapidly capitalize on a buyout of this $5 billion business. And we haven't even mentioned Blueprint's other approved drug, which is for a rare disease called mastocytosis and has an addressable market in the U.S. of at least $800 million.\nThe safe rare-disease tuck-in\nWhen Aurinia Pharmaceuticals' (NASDAQ:AUPH) Lupkynis was approved in January, it became the first oral therapy approved for lupus nephritis that doesn't require monitoring of drug levels. Lupus nephritis is an autoimmune disorder that's especially harsh on the kidneys, with approximately 10% to 30% of patients experiencing kidney failure within 15 years, despite current therapies.\nThis disease affects about 80,000 to 100,000 people in the U.S., but fortunately, when combined with current standards of care, Aurinia's drug is more likely to improve kidney function. In fact, 40.8% of patients see improvements in renal function after 52 treatments with Lupkynis, versus 22.5% receiving standard-of-care treatment alone.\nThe autoimmune-focused biotech expects an average annualized net revenue per patient of approximately $65,000. With at least 65,000 potential patients in the U.S., that's a total addressable market of more than $4 billion.\nEven better, this doesn't even get into the potential for Lupkynis to treat other autoimmune diseases. Pfizer already has multiple compounds aimed at various autoimmune conditions, and this $1.8 billion company seems like an obvious tuck-in acquisition for the pharma giant. It has an approved drug with a blockbuster addressable market, and that drug may have optionality for other autoimmune conditions as well (though it's not actively being studied in other diseases at the moment).\nThe next frontier in COVID treatment\nWith COVID-19 cases rising worldwide, there's a pressing need for an efficacious oral therapy that can be administered not only to hospitalized patients but also to those well enough to be given a prescription as outpatients. Pharma Atea Pharmaceuticals (NASDAQ:AVIR) reported interim phase 2 results at the end of June showing that its lead COVID-19 oral treatment, AT-527, could rapidly reduce the viral load in COVID-19 patients.\nAfter two days of treatment, patients experienced an 80% greater viral-load reduction compared to placebo -- and this difference was maintained eight days after the start of treatment. Atea partnered with Roche in October 2020 on AT-527, and the drug is now in an ongoing worldwide phase 3 trial with results due in the second half of 2021. After its raging success with BioNTech on their coronavirus vaccine, Pfizer may be willing to double down on partnerships in the COVID-19 space -- especially with Bourla's company raising its 2021 sales forecast of its partnered COVID-19 vaccine to $33.5 billion for the year.\nWith Atea valued at just $2.1 billion yet having megablockbuster potential, there's a lot of upside for Pfizer. An Atea buyout also would provide a safety net should Pfizer's own oral combination therapy for COVID, which just entered phase 2/3 trials, fizzle out.\nIf I were Albert Bourla, which would I choose? On July 22, Pfizer announced a global collaboration with Arvinas, which has a breast cancer treatment in phase 2 trials. The deal cost Pfizer $650 million upfront, as well as a $350 million equity investment and up to $1.4 billion in milestone payments. Given this, the behemoth may not be looking for another oncology company right away. And despite impressive COVID-19 data from Atea, Pfizer has its own oral coronavirus treatment early in progress, though not quite as far along in clinical trials.\nThat leaves Aurinia, which I believe to be the safest buy on the list for pharmaceutical investors -- Pfizer included. With a market cap of less than $2 billion and a potential blockbuster that has possible optionality into other autoimmune diseases, Aurinia looks undervalued and could find itself being acquired sooner rather than later.","news_type":1},"isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804669061,"gmtCreate":1627954322053,"gmtModify":1703498465246,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804669061","repostId":"1133429741","repostType":4,"repost":{"id":"1133429741","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1627953054,"share":"https://ttm.financial/m/news/1133429741?lang=&edition=fundamental","pubTime":"2021-08-03 09:10","market":"us","language":"en","title":"Apple Topples Saudi Aramco To Be The Most Profitable Fortune Global 500 Company In 2020","url":"https://stock-news.laohu8.com/highlight/detail?id=1133429741","media":"Benzinga","summary":"Apple, Inc.'s all-around product momentum has taken it to the top of the charts in terms of profitab","content":"<p><b>Apple, Inc.'s</b>&nbsp;all-around product momentum has taken it to the top of the charts in terms of profitability.</p>\n<p><b>Cupertino Tops On Profits:</b>Apple, with $67 million in profits for the fiscal year 2020, was the leader in the Fortune Global 500, released today.</p>\n<p>Apple wrested the No. 1 \"Most Profitable\" ranking&nbsp;from Saudi Arabian oil giant&nbsp;<b>Saudi Aramco,</b>which held the top spot for two straight years. The company reported profits of $49.287 billion for the year.<b>SoftBank Group Corp. - ADR</b>&nbsp;took the third position with $47.053 billion in profit.</p>\n<p><b>Walmart Inc.</b>&nbsp;was the top revenue-generating global company for the eighth consecutive year. Theretail giant&nbsp;clocked revenues of $523.964 billion for the fiscal year 2020. State-owned Chinese electricity utility&nbsp;<b>State Grid</b>&nbsp;followed with $383.906 billion in revenues.</p>\n<p><b>Amazon.com, Inc.</b>&nbsp;was in third place by virtue of its $280.522 billion revenues. The fourth and fifth places were taken by integrated oil companies&nbsp;<b>China National Petroleum</b>&nbsp;and&nbsp;<b>Sinopec Shanghai Petrochemical Co</b>.</p>\n<p><b>Apple was placed sixth in terms of revenue, a jump from the 12th position it held previously.</b></p>\n<p>The Fortune 500 companies generated revenues of $31.7 trillion, down 5%, and profits of $1.6 trillion, down  20%, the report showed. The companies employ 69.7 million people worldwide.</p>\n<p>Fortune blamed the softness relative to the previous year and&nbsp;the COVID-19 pandemic.</p>\n<p><b>Apple Juggernaut Rolls On:</b>Last week,&nbsp;Apple&nbsp;reported&nbsp;record June quarter results, with both revenues and earnings surpassing expectations.</p>\n<p>\"With 5G now in the cards and roughly 40% of its 'golden jewel'&nbsp;iPhone installed base not upgrading their phones in the last 3.5 years, Cook &amp; Co. have the stage set for a renaissance of growth in Cupertino,\" Wedbush analyst Daniel Ives said in a note reviewing the company's quarterly results.</p>\n<p>At last check, Apple shares were down 0.23% at $145.52.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Topples Saudi Aramco To Be The Most Profitable Fortune Global 500 Company In 2020</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Topples Saudi Aramco To Be The Most Profitable Fortune Global 500 Company In 2020\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-03 09:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Apple, Inc.'s</b>&nbsp;all-around product momentum has taken it to the top of the charts in terms of profitability.</p>\n<p><b>Cupertino Tops On Profits:</b>Apple, with $67 million in profits for the fiscal year 2020, was the leader in the Fortune Global 500, released today.</p>\n<p>Apple wrested the No. 1 \"Most Profitable\" ranking&nbsp;from Saudi Arabian oil giant&nbsp;<b>Saudi Aramco,</b>which held the top spot for two straight years. The company reported profits of $49.287 billion for the year.<b>SoftBank Group Corp. - ADR</b>&nbsp;took the third position with $47.053 billion in profit.</p>\n<p><b>Walmart Inc.</b>&nbsp;was the top revenue-generating global company for the eighth consecutive year. Theretail giant&nbsp;clocked revenues of $523.964 billion for the fiscal year 2020. State-owned Chinese electricity utility&nbsp;<b>State Grid</b>&nbsp;followed with $383.906 billion in revenues.</p>\n<p><b>Amazon.com, Inc.</b>&nbsp;was in third place by virtue of its $280.522 billion revenues. The fourth and fifth places were taken by integrated oil companies&nbsp;<b>China National Petroleum</b>&nbsp;and&nbsp;<b>Sinopec Shanghai Petrochemical Co</b>.</p>\n<p><b>Apple was placed sixth in terms of revenue, a jump from the 12th position it held previously.</b></p>\n<p>The Fortune 500 companies generated revenues of $31.7 trillion, down 5%, and profits of $1.6 trillion, down  20%, the report showed. The companies employ 69.7 million people worldwide.</p>\n<p>Fortune blamed the softness relative to the previous year and&nbsp;the COVID-19 pandemic.</p>\n<p><b>Apple Juggernaut Rolls On:</b>Last week,&nbsp;Apple&nbsp;reported&nbsp;record June quarter results, with both revenues and earnings surpassing expectations.</p>\n<p>\"With 5G now in the cards and roughly 40% of its 'golden jewel'&nbsp;iPhone installed base not upgrading their phones in the last 3.5 years, Cook &amp; Co. have the stage set for a renaissance of growth in Cupertino,\" Wedbush analyst Daniel Ives said in a note reviewing the company's quarterly results.</p>\n<p>At last check, Apple shares were down 0.23% at $145.52.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SFTBY":"软银集团","AAPL":"苹果","AMZN":"亚马逊","WMT":"沃尔玛"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133429741","content_text":"Apple, Inc.'s all-around product momentum has taken it to the top of the charts in terms of profitability.\nCupertino Tops On Profits:Apple, with $67 million in profits for the fiscal year 2020, was the leader in the Fortune Global 500, released today.\nApple wrested the No. 1 \"Most Profitable\" ranking from Saudi Arabian oil giant Saudi Aramco,which held the top spot for two straight years. The company reported profits of $49.287 billion for the year.SoftBank Group Corp. - ADR took the third position with $47.053 billion in profit.\nWalmart Inc. was the top revenue-generating global company for the eighth consecutive year. Theretail giant clocked revenues of $523.964 billion for the fiscal year 2020. State-owned Chinese electricity utility State Grid followed with $383.906 billion in revenues.\nAmazon.com, Inc. was in third place by virtue of its $280.522 billion revenues. The fourth and fifth places were taken by integrated oil companies China National Petroleum and Sinopec Shanghai Petrochemical Co.\nApple was placed sixth in terms of revenue, a jump from the 12th position it held previously.\nThe Fortune 500 companies generated revenues of $31.7 trillion, down 5%, and profits of $1.6 trillion, down  20%, the report showed. The companies employ 69.7 million people worldwide.\nFortune blamed the softness relative to the previous year and the COVID-19 pandemic.\nApple Juggernaut Rolls On:Last week, Apple reported record June quarter results, with both revenues and earnings surpassing expectations.\n\"With 5G now in the cards and roughly 40% of its 'golden jewel' iPhone installed base not upgrading their phones in the last 3.5 years, Cook & Co. have the stage set for a renaissance of growth in Cupertino,\" Wedbush analyst Daniel Ives said in a note reviewing the company's quarterly results.\nAt last check, Apple shares were down 0.23% at $145.52.","news_type":1},"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834264254,"gmtCreate":1629807916978,"gmtModify":1676530137326,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834264254","repostId":"2161000317","repostType":4,"repost":{"id":"2161000317","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629802463,"share":"https://ttm.financial/m/news/2161000317?lang=&edition=fundamental","pubTime":"2021-08-24 18:54","market":"us","language":"en","title":"Blackstone in talks to buy Baring's Interplex for at least $1 bln -sources","url":"https://stock-news.laohu8.com/highlight/detail?id=2161000317","media":"Reuters","summary":"HONG KONG, Aug 24 (Reuters) - Blackstone is in talks to acquire Interplex Holdings, a Singapore-base","content":"<p>HONG KONG, Aug 24 (Reuters) - Blackstone is in talks to acquire Interplex Holdings, a Singapore-based technological services provider owned by Baring Private Equity Asia (BPEA), in a deal worth at least $1 billion, according to two people with knowledge of the matter.</p>\n<p>Final negotiations could still take weeks and there is no certainty in a deal yet, said the sources, who declined to be named as the information is confidential.</p>\n<p>Blackstone has no exclusivity in the deal, they added.</p>\n<p>The U.S-based private equity firm and Hong Kong-based BPEA declined to comment. Interplex did not immediately respond to a request for comment.</p>\n<p>Bloomberg first reported the talks on Tuesday.</p>\n<p>BPEA offered S$450 million ($320 million) to buy out</p>\n<p>Interplex Holdings in December 2015 from CVC Capital Partners and the private equity arm of Standard Chartered .</p>\n<p>Interplex delisted from the Singapore bourse in April 2016 when the transaction was completed.</p>\n<p>The company designs, engineers and delivers advanced applications development and high-precision engineering solutions for customers in over 25 locations across over 13 countries, its website said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Blackstone in talks to buy Baring's Interplex for at least $1 bln -sources</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlackstone in talks to buy Baring's Interplex for at least $1 bln -sources\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 18:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HONG KONG, Aug 24 (Reuters) - Blackstone is in talks to acquire Interplex Holdings, a Singapore-based technological services provider owned by Baring Private Equity Asia (BPEA), in a deal worth at least $1 billion, according to two people with knowledge of the matter.</p>\n<p>Final negotiations could still take weeks and there is no certainty in a deal yet, said the sources, who declined to be named as the information is confidential.</p>\n<p>Blackstone has no exclusivity in the deal, they added.</p>\n<p>The U.S-based private equity firm and Hong Kong-based BPEA declined to comment. Interplex did not immediately respond to a request for comment.</p>\n<p>Bloomberg first reported the talks on Tuesday.</p>\n<p>BPEA offered S$450 million ($320 million) to buy out</p>\n<p>Interplex Holdings in December 2015 from CVC Capital Partners and the private equity arm of Standard Chartered .</p>\n<p>Interplex delisted from the Singapore bourse in April 2016 when the transaction was completed.</p>\n<p>The company designs, engineers and delivers advanced applications development and high-precision engineering solutions for customers in over 25 locations across over 13 countries, its website said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BX":"黑石"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161000317","content_text":"HONG KONG, Aug 24 (Reuters) - Blackstone is in talks to acquire Interplex Holdings, a Singapore-based technological services provider owned by Baring Private Equity Asia (BPEA), in a deal worth at least $1 billion, according to two people with knowledge of the matter.\nFinal negotiations could still take weeks and there is no certainty in a deal yet, said the sources, who declined to be named as the information is confidential.\nBlackstone has no exclusivity in the deal, they added.\nThe U.S-based private equity firm and Hong Kong-based BPEA declined to comment. Interplex did not immediately respond to a request for comment.\nBloomberg first reported the talks on Tuesday.\nBPEA offered S$450 million ($320 million) to buy out\nInterplex Holdings in December 2015 from CVC Capital Partners and the private equity arm of Standard Chartered .\nInterplex delisted from the Singapore bourse in April 2016 when the transaction was completed.\nThe company designs, engineers and delivers advanced applications development and high-precision engineering solutions for customers in over 25 locations across over 13 countries, its website said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897968152,"gmtCreate":1628868743576,"gmtModify":1676529881998,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Great free stock","listText":"Great free stock","text":"Great free stock","images":[{"img":"https://static.tigerbbs.com/c73301097dba2759a5114cb01c22943c","width":"1200","height":"2686"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897968152","isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":899108156,"gmtCreate":1628166151775,"gmtModify":1703502392402,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Like me please","listText":"Like me please","text":"Like me please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899108156","repostId":"2157015435","repostType":4,"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804661501,"gmtCreate":1627954459403,"gmtModify":1703498469776,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/804661501","repostId":"1113979236","repostType":4,"isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805049439,"gmtCreate":1627828042521,"gmtModify":1703496343938,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Like and shaee","listText":"Like and shaee","text":"Like and shaee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805049439","repostId":"1122171439","repostType":4,"isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804668817,"gmtCreate":1627954497639,"gmtModify":1703498470745,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Like and comment please","listText":"Like and comment please","text":"Like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804668817","repostId":"2156823112","repostType":4,"isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109921064,"gmtCreate":1619659987858,"gmtModify":1704727543798,"author":{"id":"3581829779229670","authorId":"3581829779229670","name":"rolandc85","avatar":"https://static.tigerbbs.com/5d74e3db147b390181f1a2d1e1fe79f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581829779229670","authorIdStr":"3581829779229670"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109921064","repostId":"1137964402","repostType":4,"repost":{"id":"1137964402","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619651546,"share":"https://ttm.financial/m/news/1137964402?lang=&edition=fundamental","pubTime":"2021-04-29 07:12","market":"us","language":"en","title":"Apple reports another blowout quarter with sales up 54%, authorizes $90 billion in share buybacks","url":"https://stock-news.laohu8.com/highlight/detail?id=1137964402","media":"Tiger Newspress","summary":"Apple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and significantly stronger profits than Wall Street expected.Apple did not issue official guidance for what it expects in the quarter ending in June.Apple authorized $90 billion in share buybacks.Apple stock rose over 4% at one point in extended trading.Apple reported double-digit growth in every single one of its product categories, and its most important product line, the iPhone, was up 65","content":"<p><b>KEY POINTS</b></p><ul><li>Apple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and&nbsp;significantly stronger profits than Wall Street expected.</li><li>Apple did not issue official guidance for what it expects in the quarter ending in June.</li><li>Apple authorized $90 billion in share buybacks.</li></ul><p>Apple&nbsp;reported&nbsp;a blowout quarter&nbsp;on Wednesday, announcing companywide sales up 54% higher than last year, and&nbsp;significantly stronger profits than Wall Street expected.</p><p>Apple stock rose over 4% at one point in extended trading.</p><p><img src=\"https://static.tigerbbs.com/4e791f63f460807906f1793c2d58933e\" tg-width=\"1302\" tg-height=\"833\"></p><p>Apple reported double-digit growth in every single one of its product categories, and its&nbsp;most important product line, the iPhone, was up 65.5% from last year. Its Mac and iPad sales&nbsp;did&nbsp;better, with its computers up 70.1% and iPad&nbsp;sales&nbsp;growing nearly 79% on an annual basis.</p><p>Apple said it would increase its dividend by 7%&nbsp;to $0.22 per share&nbsp;and authorized $90 billion in share buybacks, which is significantly higher than last year’s $50 billion outlay&nbsp;and 2019′s $75 billion.</p><p>Here’s how Apple did versus Refinitiv estimates:</p><ul><li><b>EPS</b>:&nbsp;$1.40&nbsp;vs. $0.99 estimated</li><li><b>Revenue</b>:&nbsp;$89.58&nbsp;billion&nbsp;vs. $77.36&nbsp;billion&nbsp;estimated, up 53.7% year-over-year</li><li><b>iPhone revenue</b>:&nbsp;$47.94 billion&nbsp;vs. $41.43&nbsp;billion&nbsp;estimated, up&nbsp;65.5% year-over-year</li><li><b>Services revenue</b>:&nbsp;$16.90 billion&nbsp;vs. $15.57&nbsp;billion&nbsp;estimated, up 26.7% year over&nbsp;year</li><li><b>Other Products revenue</b>:&nbsp;$7.83&nbsp;billion&nbsp;vs. $7.79&nbsp;billion&nbsp;estimated,&nbsp;up 24%&nbsp;year-over-year</li><li><b>Mac revenue</b>:&nbsp;$9.10&nbsp;billion&nbsp;vs. $6.86&nbsp;billion&nbsp;estimated, up 70.1% year-over-year</li><li><b>iPad revenue</b>:&nbsp;$7.80 billion&nbsp;vs. $5.58&nbsp;billion&nbsp;estimated, up 78.9% year-over-year</li><li><b>Gross margin</b>:&nbsp;42.5% vs. 39.8%&nbsp;estimated</li></ul><p>Apple did not issue official guidance for what it expects in the quarter ending in June. It hasn’t provided revenue&nbsp;guidance since the start of the pandemic, citing uncertainty.&nbsp;This is Apple’s second quarter in a row with double-digit growth in all product categories.&nbsp;Apple CFO Luca Maestri told analysts that the company expects June quarter revenue to rise by double digits year-over-year, although it faces some supply shortages due to the worldwide chip shortage.</p><p>Apple has said in the past months that its business has been boosted by the pandemic as consumers&nbsp;and businesses&nbsp;bought&nbsp;computers&nbsp;to work and entertain themselves while at home. But Apple’s strong results in the quarter suggest that the trend may persist as more economies&nbsp;open up.</p><p>Or, as Apple CEO Tim Cook said in a statement: “This quarter reflects both the enduring ways our products have helped our users meet this&nbsp;moment in their own lives, as well as the optimism consumers seem to feel about better days&nbsp;ahead for all of us.”</p><p>Mac sales were up 70%, and Cook said that the result was “fueled by” the company’s introduction of its Mac&nbsp;laptops&nbsp;that used its own M1 chips&nbsp;for longer battery life, instead of processors sold by&nbsp;Intel.&nbsp;iPad sales were up&nbsp;nearly 79% year-over-year.</p><p>Neither of those&nbsp;results&nbsp;include iPad Pro or iMac models the company announced in March, which are expected to drive additional demand.</p><p>“We’re seeing strong first-time buyers on the Mac&nbsp;…&nbsp;it continues to run just south of 50%,” Cook told CNBC’s Josh Lipton. “And, in China, it’s even higher than that&nbsp;…&nbsp;it’s more around two-thirds. And that speaks to people preferring to work on the Mac.”</p><p>Apple’s iPhone also reported strong results this quarter, quelling fears that the current annual cycle could slow down. Last year, Apple released iPhones with a new exterior design and 5G support, which many investors believed could prompt a major upgrade cycle, which this quarter’s results indicate.</p><p>In greater China, which includes the mainland, Hong Kong, and Taiwan,&nbsp;Apple’s revenue increased over&nbsp;87% year-over-year to $17.73 billion, although the comparison is to a quarter last year in which China was largely shut down in the early days of the pandemic.&nbsp;Every other geographical category, including the Americas and Europe, were also up on an annual basis.</p><p><img src=\"https://static.tigerbbs.com/37a8b45c92174e3c9ab224d9a85f5e2d\" tg-width=\"1910\" tg-height=\"1114\" referrerpolicy=\"no-referrer\"></p><p>Apple’s&nbsp;high-margin&nbsp;services business, including iCloud, App Store, and subscriptions like Apple Music, also showed 26.7% growth.</p><p>One metric that Apple uses to show the growth in services is the number of subscriptions it has, which not only include its own subscriptions like Apple One, but also subscriptions through its App Store.</p><p>“We now have over 660 million paid subscriptions across the services on the platform, and that’s up 40 million from the previous quarter, which is an acceleration from 35 million,” Cook told CNBC.</p><p>However, Apple’s App Store has been challenged by lawmakers and companies that say it costs too much and has too much power. A closely-watched trial with Fortnite maker Epic Games over App Store policies kicks off next week.</p><p>“The App Store has been an economic miracle. Last year, the estimates are that there was over a half a trillion dollars of economic activity because of the store. And, so, this has been just an economic gamechanger for not only the United States, but several countries around the world. And, we’re going to go in and tell our story. And we’ll see where it goes. But, we’re confident,” Cook told CNBC.</p><p>Apple’s gross margin was also unusually elevated for the company. Most quarters, it tends to be in the 38% to 39% range, but in the quarter ending in March, Apple reported 42.5% margins.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple reports another blowout quarter with sales up 54%, authorizes $90 billion in share buybacks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple reports another blowout quarter with sales up 54%, authorizes $90 billion in share buybacks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-29 07:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>KEY POINTS</b></p><ul><li>Apple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and&nbsp;significantly stronger profits than Wall Street expected.</li><li>Apple did not issue official guidance for what it expects in the quarter ending in June.</li><li>Apple authorized $90 billion in share buybacks.</li></ul><p>Apple&nbsp;reported&nbsp;a blowout quarter&nbsp;on Wednesday, announcing companywide sales up 54% higher than last year, and&nbsp;significantly stronger profits than Wall Street expected.</p><p>Apple stock rose over 4% at one point in extended trading.</p><p><img src=\"https://static.tigerbbs.com/4e791f63f460807906f1793c2d58933e\" tg-width=\"1302\" tg-height=\"833\"></p><p>Apple reported double-digit growth in every single one of its product categories, and its&nbsp;most important product line, the iPhone, was up 65.5% from last year. Its Mac and iPad sales&nbsp;did&nbsp;better, with its computers up 70.1% and iPad&nbsp;sales&nbsp;growing nearly 79% on an annual basis.</p><p>Apple said it would increase its dividend by 7%&nbsp;to $0.22 per share&nbsp;and authorized $90 billion in share buybacks, which is significantly higher than last year’s $50 billion outlay&nbsp;and 2019′s $75 billion.</p><p>Here’s how Apple did versus Refinitiv estimates:</p><ul><li><b>EPS</b>:&nbsp;$1.40&nbsp;vs. $0.99 estimated</li><li><b>Revenue</b>:&nbsp;$89.58&nbsp;billion&nbsp;vs. $77.36&nbsp;billion&nbsp;estimated, up 53.7% year-over-year</li><li><b>iPhone revenue</b>:&nbsp;$47.94 billion&nbsp;vs. $41.43&nbsp;billion&nbsp;estimated, up&nbsp;65.5% year-over-year</li><li><b>Services revenue</b>:&nbsp;$16.90 billion&nbsp;vs. $15.57&nbsp;billion&nbsp;estimated, up 26.7% year over&nbsp;year</li><li><b>Other Products revenue</b>:&nbsp;$7.83&nbsp;billion&nbsp;vs. $7.79&nbsp;billion&nbsp;estimated,&nbsp;up 24%&nbsp;year-over-year</li><li><b>Mac revenue</b>:&nbsp;$9.10&nbsp;billion&nbsp;vs. $6.86&nbsp;billion&nbsp;estimated, up 70.1% year-over-year</li><li><b>iPad revenue</b>:&nbsp;$7.80 billion&nbsp;vs. $5.58&nbsp;billion&nbsp;estimated, up 78.9% year-over-year</li><li><b>Gross margin</b>:&nbsp;42.5% vs. 39.8%&nbsp;estimated</li></ul><p>Apple did not issue official guidance for what it expects in the quarter ending in June. It hasn’t provided revenue&nbsp;guidance since the start of the pandemic, citing uncertainty.&nbsp;This is Apple’s second quarter in a row with double-digit growth in all product categories.&nbsp;Apple CFO Luca Maestri told analysts that the company expects June quarter revenue to rise by double digits year-over-year, although it faces some supply shortages due to the worldwide chip shortage.</p><p>Apple has said in the past months that its business has been boosted by the pandemic as consumers&nbsp;and businesses&nbsp;bought&nbsp;computers&nbsp;to work and entertain themselves while at home. But Apple’s strong results in the quarter suggest that the trend may persist as more economies&nbsp;open up.</p><p>Or, as Apple CEO Tim Cook said in a statement: “This quarter reflects both the enduring ways our products have helped our users meet this&nbsp;moment in their own lives, as well as the optimism consumers seem to feel about better days&nbsp;ahead for all of us.”</p><p>Mac sales were up 70%, and Cook said that the result was “fueled by” the company’s introduction of its Mac&nbsp;laptops&nbsp;that used its own M1 chips&nbsp;for longer battery life, instead of processors sold by&nbsp;Intel.&nbsp;iPad sales were up&nbsp;nearly 79% year-over-year.</p><p>Neither of those&nbsp;results&nbsp;include iPad Pro or iMac models the company announced in March, which are expected to drive additional demand.</p><p>“We’re seeing strong first-time buyers on the Mac&nbsp;…&nbsp;it continues to run just south of 50%,” Cook told CNBC’s Josh Lipton. “And, in China, it’s even higher than that&nbsp;…&nbsp;it’s more around two-thirds. And that speaks to people preferring to work on the Mac.”</p><p>Apple’s iPhone also reported strong results this quarter, quelling fears that the current annual cycle could slow down. Last year, Apple released iPhones with a new exterior design and 5G support, which many investors believed could prompt a major upgrade cycle, which this quarter’s results indicate.</p><p>In greater China, which includes the mainland, Hong Kong, and Taiwan,&nbsp;Apple’s revenue increased over&nbsp;87% year-over-year to $17.73 billion, although the comparison is to a quarter last year in which China was largely shut down in the early days of the pandemic.&nbsp;Every other geographical category, including the Americas and Europe, were also up on an annual basis.</p><p><img src=\"https://static.tigerbbs.com/37a8b45c92174e3c9ab224d9a85f5e2d\" tg-width=\"1910\" tg-height=\"1114\" referrerpolicy=\"no-referrer\"></p><p>Apple’s&nbsp;high-margin&nbsp;services business, including iCloud, App Store, and subscriptions like Apple Music, also showed 26.7% growth.</p><p>One metric that Apple uses to show the growth in services is the number of subscriptions it has, which not only include its own subscriptions like Apple One, but also subscriptions through its App Store.</p><p>“We now have over 660 million paid subscriptions across the services on the platform, and that’s up 40 million from the previous quarter, which is an acceleration from 35 million,” Cook told CNBC.</p><p>However, Apple’s App Store has been challenged by lawmakers and companies that say it costs too much and has too much power. A closely-watched trial with Fortnite maker Epic Games over App Store policies kicks off next week.</p><p>“The App Store has been an economic miracle. Last year, the estimates are that there was over a half a trillion dollars of economic activity because of the store. And, so, this has been just an economic gamechanger for not only the United States, but several countries around the world. And, we’re going to go in and tell our story. And we’ll see where it goes. But, we’re confident,” Cook told CNBC.</p><p>Apple’s gross margin was also unusually elevated for the company. Most quarters, it tends to be in the 38% to 39% range, but in the quarter ending in March, Apple reported 42.5% margins.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137964402","content_text":"KEY POINTSApple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and significantly stronger profits than Wall Street expected.Apple did not issue official guidance for what it expects in the quarter ending in June.Apple authorized $90 billion in share buybacks.Apple reported a blowout quarter on Wednesday, announcing companywide sales up 54% higher than last year, and significantly stronger profits than Wall Street expected.Apple stock rose over 4% at one point in extended trading.Apple reported double-digit growth in every single one of its product categories, and its most important product line, the iPhone, was up 65.5% from last year. Its Mac and iPad sales did better, with its computers up 70.1% and iPad sales growing nearly 79% on an annual basis.Apple said it would increase its dividend by 7% to $0.22 per share and authorized $90 billion in share buybacks, which is significantly higher than last year’s $50 billion outlay and 2019′s $75 billion.Here’s how Apple did versus Refinitiv estimates:EPS: $1.40 vs. $0.99 estimatedRevenue: $89.58 billion vs. $77.36 billion estimated, up 53.7% year-over-yeariPhone revenue: $47.94 billion vs. $41.43 billion estimated, up 65.5% year-over-yearServices revenue: $16.90 billion vs. $15.57 billion estimated, up 26.7% year over yearOther Products revenue: $7.83 billion vs. $7.79 billion estimated, up 24% year-over-yearMac revenue: $9.10 billion vs. $6.86 billion estimated, up 70.1% year-over-yeariPad revenue: $7.80 billion vs. $5.58 billion estimated, up 78.9% year-over-yearGross margin: 42.5% vs. 39.8% estimatedApple did not issue official guidance for what it expects in the quarter ending in June. It hasn’t provided revenue guidance since the start of the pandemic, citing uncertainty. This is Apple’s second quarter in a row with double-digit growth in all product categories. Apple CFO Luca Maestri told analysts that the company expects June quarter revenue to rise by double digits year-over-year, although it faces some supply shortages due to the worldwide chip shortage.Apple has said in the past months that its business has been boosted by the pandemic as consumers and businesses bought computers to work and entertain themselves while at home. But Apple’s strong results in the quarter suggest that the trend may persist as more economies open up.Or, as Apple CEO Tim Cook said in a statement: “This quarter reflects both the enduring ways our products have helped our users meet this moment in their own lives, as well as the optimism consumers seem to feel about better days ahead for all of us.”Mac sales were up 70%, and Cook said that the result was “fueled by” the company’s introduction of its Mac laptops that used its own M1 chips for longer battery life, instead of processors sold by Intel. iPad sales were up nearly 79% year-over-year.Neither of those results include iPad Pro or iMac models the company announced in March, which are expected to drive additional demand.“We’re seeing strong first-time buyers on the Mac … it continues to run just south of 50%,” Cook told CNBC’s Josh Lipton. “And, in China, it’s even higher than that … it’s more around two-thirds. And that speaks to people preferring to work on the Mac.”Apple’s iPhone also reported strong results this quarter, quelling fears that the current annual cycle could slow down. Last year, Apple released iPhones with a new exterior design and 5G support, which many investors believed could prompt a major upgrade cycle, which this quarter’s results indicate.In greater China, which includes the mainland, Hong Kong, and Taiwan, Apple’s revenue increased over 87% year-over-year to $17.73 billion, although the comparison is to a quarter last year in which China was largely shut down in the early days of the pandemic. Every other geographical category, including the Americas and Europe, were also up on an annual basis.Apple’s high-margin services business, including iCloud, App Store, and subscriptions like Apple Music, also showed 26.7% growth.One metric that Apple uses to show the growth in services is the number of subscriptions it has, which not only include its own subscriptions like Apple One, but also subscriptions through its App Store.“We now have over 660 million paid subscriptions across the services on the platform, and that’s up 40 million from the previous quarter, which is an acceleration from 35 million,” Cook told CNBC.However, Apple’s App Store has been challenged by lawmakers and companies that say it costs too much and has too much power. A closely-watched trial with Fortnite maker Epic Games over App Store policies kicks off next week.“The App Store has been an economic miracle. Last year, the estimates are that there was over a half a trillion dollars of economic activity because of the store. And, so, this has been just an economic gamechanger for not only the United States, but several countries around the world. And, we’re going to go in and tell our story. And we’ll see where it goes. But, we’re confident,” Cook told CNBC.Apple’s gross margin was also unusually elevated for the company. Most quarters, it tends to be in the 38% to 39% range, but in the quarter ending in March, Apple reported 42.5% margins.","news_type":1},"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}